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Abstract 
  During the last decades, medical observations and multiscale data concerning tumor growth 
are mounting. At the same time, contemporary imaging techniques well established in clinical 
practice, provide a variety of information on real-time, in-vivo tumor growth. Mathematical 
and in-silico modeling has been widely recruited to provide means for further understanding 
of pertinent biological phenomena. However, despite the vast amounts of new evidence 
compiled by medical doctors, there are still many aspects of tumor growth that remain largely 
unknown. There is still a large variety of mechanisms to be better understood and therefore, 
many hypotheses to be tested. To approach this problem, starting from mathematical 
elaborations, we have developed a model of the early phases of tumor growth consisting of 
several algorithmic modules, each one corresponding to a particular biological mechanism. 
The modularity of the model allows keeping track of the assumptions made in each step and 
facilitates re-adjustment, in case new hypotheses need to be considered. Simulations showed 
good qualitative agreement with biological observations, and revealed a non-trivial interplay 
between between oxygen requirements of cancer cells and their maximum mitosis rates. The 
proposed model has, at least in principle, the potential to exploit data from contemporary 
imaging techniques and is eligible for utilizing multicore computation.   
Keywords: theoretical oncology; multiscale cancer modeling; partial differential equations; 
cellular diffusion; chemical diffusion 
   
 I.Introduction 
  Cancer is one of the main causes of mortality in the world. Statistics estimate that about one 
fifth of the population will suffer from cancer at some point of their lives [1]. Cancer is a 
category of diseases, which share several common features including  sustained, uncontrolled 
cellular proliferation,  resistance of cell death, induction of angiogenesis and activation of 
invasion and metastasis mechanisms [2]. 
  The exact mechanisms that initiate cancer development remain largely unknown. However, 
it is widely accepted that cancer originates from cells which, due to various gene mutations, 
escape the body’s natural mechanisms of controlling the balance between cell proliferation 
and cell death [3]. These cells create a clump which grows faster than host cells. However, 
this small tumor grows with a decreasing rate; as the tumor grows, disorganization of the host 
vasculature and  limited diffusion of nutrients to the center of the tumor lead to the formation 
a necrotic core inside the tumor [4, 5]. Cells in the outer rim of the tumor proliferate, while 
cells in the interior die. For the tumor to grow up to becoming malignant, it needs to establish 
its own blood supply network, a process called angiogenesis. This process begins with tumor 
cells secreting molecules generally called tumor angiogenesis factors (TAF). TAFs  induce 
proliferation and migration of endothelial cells, causing host vessels to form capillary sprouts. 
These sprouts randomly fuse with each other (anastomosis) and form loops, through which 
blood can flow. Repetition of these steps forms the tumor induced vasculature [6]. However, 
this tumor induced vasculature is highly disorganized, tortuous and dilated [7].  
  Evidently, during both the avascular and vascular phase of tumor development, the provision 
of nutrients to tumor cells through the blood supply network is highly inhomogeneous and 
time varying [4, 8, 9, 10]. In fact, many studies  have shown that tumors contain hypoxic and 
hypoglycemic regions, particularly near the center which affect local cell proliferation and 
death rates [4, 11, 12 and references therein]. Contemporary imaging techniques such as 
positron emission tomography (PET) and magnetic resonance imaging (MRI) in its various 
forms (e.g. T1 gadolinium enhanced MRI, T2 MRI and  Diffusion Weighted MRI) provide 
information on a variety of details concerning tumor microenvironment, such as glucose 
uptake rates and metabolism, oxygen distribution, cell density and  proliferation. [13, 14, 15, 
16]    
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  During the last decades, in-silico modeling appears to be an invaluable tool for simulating 
complex biological processes, providing means for further understanding of related 
phenomena. In the following sections of this paper we develop a mathematical/ computational 
model that takes into account a variety of phenomena observed during the early (pre-
neovascular) phases of tumor growth in a 3-dimensional, inhomogeneous and  time-varying 
chemical environment. Since pertinent medical and biological literature on the subject shows 
that the vast majority of results are conclusive only up to a point, there are still a many 
qualitative and quantitative aspects of  tumor progression that remain largely unknown, with 
angiogenesis-related phenomena forming a concrete class of such examples. Consequently, 
from a modeling perspective, it is almost impossible to avoid assumptions.  Therefore, in this 
work, special care has been taken such that the model presented is modular, that is, it consists 
of several algorithmic modules, each one corresponding to a separate biological phenomenon 
encountered in tumor progression. The proposed methodology allows keeping track of the 
assumptions made in each part of the model, and facilitates model readjustment, in case new 
biological evidence emerge and need to be considered. 
 
II.Related literature 
 Modelling the chemical microenvironment and growth of tumors has a long history. In the 
last 30 years, a plethora of models has appeared in the literature based on a variety of 
approaches, both continuous and discrete. In this section we review related literature. This 
review is by no means complete; it mainly describes previous work that inspired the work on 
this paper. For a comprehensive review, we refer to [17]. 
 Early attempts in the subject include  [18 ,19]. In this work, the authors conducted a series of 
experiments and derived empirical equations quantifying the effects of oxygen and glucose 
concentrations and extracellular pH on cell metabolism and growth rate . Their mathematical 
approach was based on the reaction-diffusion equation, assuming spherical symmetry. They 
exploited the derived empirical equations by introducing appropriate terms taking account of 
cell metabolism, consumption of oxygen, aerobic/anaerobic breakdown of glucose and 
respective waste products. A theoretical study on the subject is that of [20]. In this work the 
authors used convection-diffusion equations and assumed spherical symmetry to model the 
spatial evolution of living and dead cells and how they are affected by the concentration of 
single generic nutrient. This approach was extended in [21, 22] which incorporated  transport 
and metabolism of glucose, oxygen and lactate to their model. A different approach was taken 
in [23, 24]. In these works the authors used discrete, 2-dimensional cellular automata to 
account for single cell interactions with the environment and reaction-diffusion equations to 
model the evolution of chemical fields. In [25,26],  the authors modeled cell surface receptors 
sensing the environment and subcellular molecular pathways by using an additional neural 
network determining the respective cellular phenotype. Spatially averaged cellular automata 
addressing additionally various treatment modalities include [27,28]. In a multiscale 
approach, the authors in [29] use a 3-dimensional lattice at the cellular level, a simplified 
protein regulatory network at the subcellular level and reaction-diffusion equations for the 
chemical fields. More recent similar approaches include [30,31,32]. Models explicitly 
incorporating vasculature and angiogenesis include [33,35]. 
 Both continuum and discrete approaches were taken and compared in the series of papers 
[36,37]. In the continuum approach the authors used reaction-diffusion equations to model the 
spatiotemporal evolution of live and necrotic cells. In the discrete approach they used an off-
lattice Voronoi/Delaunay cell model taking account of cell-cell interactions. Both approaches 
used reaction-diffusion equations to model the spatiotemporal evolution of glucose and 
oxygen concentrations. Interestingly, the authors conclude that when considering macroscopic 
quantities, continuous reaction-diffusion type models are adequate to explain global 
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properties. According to the authors, agent-based models are difficult to discriminate, since 
most often, pertinent microscopic data regarding tissue morphology are not available. 
However, agent-based models have the ability to incorporate microscopic cellular properties 
determined by independently conducted experiments. 
  Our model is based on a systematic discretization of the continuous reaction- diffusion 
equations. We do not explicitly include vasculature and angiogenesis related phenomena in 
our model. As previously mentioned, angiogenesis is a highly complex phenomenon, and 
pertinent biological data are sparse. Instead, we  model the effects of these phenomena on 
tumor growth by introducing macroscopic quantities like local nutrient provision, 
consumption and diffusion, which may be assessed or deduced by PET or MRI imaging 
techniques. 
 
III. Modeling the diffusion of particles 
  A central notion, present in a vast variety of models regarding tumor growth, is that of 
diffusion.  In this section, we will present a method to model this phenomenon,  starting by 
the well-known reaction-diffusion partial differential equation. 
                                                        
𝜕𝑐
𝜕𝑡
= 𝛻 ∙ (𝐷𝛻𝑐)                                                                  (1) 
where 𝑐(𝑥, 𝑡) is the concentration of the particles under consideration (cells or molecules) at 
time 𝑡 and location 𝑥, and 𝐷 the diffusion tensor of the species in the surrounding material.  
This equation has been widely used to model cell diffusion, particularly in the case of 
glioblastoma, as well as diffusion of molecules in tissue. 
In the case of isotropic diffusion D is a constant scalar, and equation (1) reduces to  
                                                        
𝜕𝑐
𝜕𝑡
= 𝐷𝛥𝑥𝑐                                                                        (2) 
  where 𝛥𝑥 is the Laplace operator in  R
3. 
In [38] we elaborated on the observation that (2) is the Fokker-Planck equation corresponding 
to the stochastic differential equation  
                                                    𝑑𝑥𝑡 = √2𝐷 ∙ 𝑑𝐵𝑡                                                                  (3) 
where Bt denotes standard Brownian motion in R
3. Given the initial position xo of a particle, 
the distribution of the random variable 𝑥𝑡 (i.e. the solution of (3) at time 𝑡) provides the 
probability distribution over all possible locations of this particle at time t. Given the initial 
position of a particle in terms of a probability distribution c(𝑥, 0), the probability distribution 
c(𝑥, 𝑡) can be found by two equivalent ways: By solving (2) as a partial differential equation 
with initial value c(𝑥, 0), to find the evolution of this distribution through time, or 
equivalently, by solving the stochastic differential equation (3) with initial distribution 𝑐(𝑥, 0) 
to find the probability distribution of the random variable 𝑥𝑡. 
  In case we want to study the movement of many particles, that is, molecules or cells located 
within a specified anatomic region, this notion of distribution is interpreted  as follows: 
Integration of 𝑐(𝑥, 𝑡) over an area 𝐴 of  𝑅3 yields the fraction of the total particle population 
that is located in 𝐴. 
  In the remaining part of this section, by furtherly elaborating on the previous observations, 
we will present a systematic discretization the above equations, in both time and space. This 
method will subsequently be used to  simulate the evolution of phenomena that can be 
modeled by the preceding equations. 
 We start by considering the initial value problem  
                                                       
𝜕𝑐
𝜕𝑡
= 𝐷𝛥𝑥𝑐                                                                         (4) 
                                                   𝑐(𝑥, 𝑡𝑜) = 𝑓(𝑥)                                                                     (5) 
We assume that                  
                                                 ∫ 𝑓(𝑥)𝑑𝑥
𝑅3
= 1                                                                       (6) 
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i.e., f is a probability density function and that f(x) is supported in a compact subset  𝑈 ⊆ R3, 
i.e. 𝑓(𝑥) > 0 if and only if  𝑥 ∈ 𝑈.  Equation (5) provides the initial value of the problem, that 
is, the distribution of the species in 𝑅3 at   𝑡 = 𝑡𝑜.  
The problem defined by equations (4), (5) is well-posed and for t ≥ to has the solution  
                    𝑐(𝑥, 𝑡) = ∫ 𝐺(𝑥, 𝑦, 𝑡 − 𝑡𝑜)𝑓(𝑦)𝑑𝑦𝑅3 = ∫ 𝐺(𝑥, 𝑦, 𝑡 − 𝑡𝑜)𝑓(𝑦)𝑑𝑦𝑈                       (7) 
Where G(x, y, t − to) is the Gaussian kernel  
                              𝐺(𝑥, 𝑦, 𝑡 − 𝑡𝑜)= 
1
(√4𝜋𝐷(𝑡−𝑡𝑜))
3 𝑒
−
‖𝑥−𝑦‖2
4𝐷(𝑡−𝑡𝑜)                                                     (8) 
In probabilistic terms, equation (7) provides  the probability density function (pdf) of the 
distribution of the species at time 𝑡 given that the probability density function of the 
respective distribution at 𝑡 = 𝑡𝑜 is 𝑓(𝑦). Equivalently, we can calculate the probability for a 
particle to lie within a set 𝑉 ⊆ R3 (including the case 𝑉⋂𝑈 ≠⊘) at time t given that its  
position at  t = to  is distributed according to f(y)  
𝑃𝑟(𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑙𝑖𝑒𝑠 𝑖𝑛 𝑉 𝑎𝑡 𝑡𝑖𝑚𝑒 𝑡 | 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒′𝑠 𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛 𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑝𝑑𝑓 𝑖𝑠 𝑓(𝑦)) = 
                                       ∫ (∫ 𝐺(𝑥, 𝑦, 𝑡 − 𝑡𝑜)𝑓(𝑦)𝑑𝑦𝑈 ) 𝑑𝑥𝑉                                                    (9) 
Each of the integrals that appear in equation (9) is a triple integral. The complete calculation 
implied in (9) can be carried out numerically. 
We can drop the assumption in equation (6) and perform the same analysis. In this case, 𝑓(𝑥) 
represents the local density of particles at each point 𝑥. Integrating 𝑓 over  𝑅3 provides the 
total population of the particles under consideration. The integral of  𝑓 over a subset 𝐴 ⊆ 𝑅3 
provides the population of the particles that lies within 𝐴. Calculation of the integral  
𝐼 = ∫ (∫ 𝐺(𝑥, 𝑦, 𝑡 − 𝑡𝑜)𝑓(𝑦)𝑑𝑦
𝑈
) 𝑑𝑥
𝑉
 
yields the population that lies within the set 𝑉 at time 𝑡, when we know that the initial local 
density of the particles at time 𝑡 = 𝑡𝑜  is 𝑓. 
We proceed now to the discretization of the above equations. Let us assume that the diffusion 
of the particles under consideration takes place in a cubic lattice consisting of  𝑁 × 𝑁 × 𝑁 
geometrical cells (voxels). Each voxel is a cube of  dimensions 𝛥𝑠 ×  𝛥𝑠 × 𝛥𝑠. We fix a 
temporal discretization step equal to 𝛥𝜏. Voxels in that cubic lattice can be classified into 4 
categories, depending on the number of their neighboring voxels within the lattice. Voxels in 
the interior of the lattice have 26 neighbors. Voxels at the outer faces of the lattice have 17 
neighbors. Voxels at the outer edges of the lattice have 11 neighbors and voxels at the outer 
vertices of the lattice have 7 neighbors. Additionally, for each particular voxel, its 
neighboring voxels fall into 3 categories: the ones that share a common face, the ones that 
share a common edge and the ones that share a common vertice with the particular voxel. 
The first key step to the discretization process we propose is to assume that at each discrete 
time point, the distribution of the species under consideration within each voxel is uniform. 
Considering that the quantities of cells or molecules within a 𝑚𝑚3 are in the order of 106 and 
1012 respectively, we can deduce that this assumption is safe, as long the voxel size remains 
in the order of  𝑚𝑚3. 
 Under this assumption, at any discrete time point 𝑡 and for any  pair of voxels 𝐴 and 𝐵 (not 
necessarily different) we can calculate the probability, for a particle to lie within 𝐵 at time 
𝑡 + 𝛥𝜏 given that it’s position at time 𝑡 is a uniformly distributed (u.d.) random variable 
supported in 𝐴, by performing the calculation implied in equation (9) for 𝑈 = 𝐴 , 𝑉 = 𝐵 and 
𝑓 = (1/𝑣𝑜𝑙(𝐴))1𝐴 . Here, 𝑣𝑜𝑙(𝐴) is the volume of voxel  𝐴  (= 𝛥𝑠
3 for all voxels) and 1𝐴 is 
the indicator function of  𝐴 as a subset of  𝑅3.  
 Under the aforementioned assumption, equation (9) takes the form 
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𝑃𝑟(𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑙𝑖𝑒𝑠 𝑖𝑛 𝐵 𝑎𝑡 𝑡𝑖𝑚𝑒 𝑡 + 𝛥𝜏 | 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑙𝑖𝑒𝑠 𝑖𝑛 𝐴 𝑎𝑡 𝑡𝑖𝑚𝑒 𝑡, 𝑢. 𝑑. ) =
                             ∫ (∫ 𝐺(𝑥, 𝑦, 𝛥𝜏 )(1/𝑣𝑜𝑙(𝐴))1𝐴𝑑𝑦𝐴 ) 𝑑𝑥𝐵                                                    (10) 
In the remaining part of the paper, for any pair of voxels  A and B (not necessarily different) 
we will use the abbreviation Pr (A → B) for the probability implied in equation (10).  
Supposing that the quantity of the particles within voxel 𝐴 at time 𝑡 is 𝑄, the probability 
calculated from equation (10) can be interpreted as the fraction of  𝑄 that will lie within voxel 
𝐵 at time  𝑡 + 𝛥𝜏 . Indeed, let us assume for the moment that = (𝑄/𝑣𝑜𝑙(𝐴))1𝐴 , that is,  𝑓 
represents the (uniform) local density of particles within 𝐴 instead of a probability density 
function. As we mentioned previously, in this case, the integral 𝐼 yields the population that 
lies within the voxel B at time 𝑡 + 𝛥𝜏, when we know that the local density of the species at 
time 𝑡  is 𝑓. We calculate 
𝐼 = ∫ (∫ 𝐺(𝑥, 𝑦, 𝛥𝜏 )𝑓(𝑦)𝑑𝑦
𝑈
) 𝑑𝑥
𝑉
= 
∫ (∫ 𝐺(𝑥, 𝑦, 𝛥𝜏 )(𝑄/𝑣𝑜𝑙(𝐴))1𝐴𝑑𝑦𝐴 ) 𝑑𝑥𝐵 = 
𝑄 ∙ ∫ (∫ 𝐺(𝑥, 𝑦, 𝛥𝜏 )(1/𝑣𝑜𝑙(𝐴))1𝐴𝑑𝑦𝐴 ) 𝑑𝑥𝐵 = 
𝑄 ∙ 𝑃𝑟(𝐴 → 𝐵)  
where the last equality is inferred from equation (10). 
Let 𝐴 denote a voxel not lying at the boundary of the lattice and  𝐵𝑖, 𝑖 = 1, … ,26  his 
neighbors. The second key step to our discretization process is to choose the voxels’ edge 
length 𝛥𝑠 and the time step 𝛥𝜏 such that, from one time instant to the next one, for a voxel in 
the interior of the lattice, it’s population diffuses at most in his neighbors. Mathematically, 
this means that 𝛥𝑠 and 𝛥𝜏 should be chosen such that  
                                          𝑃𝑟(𝐴 → 𝐴) + ∑ Pr(𝐴 → 𝐵𝑖) = 1
26
𝑖=1                                             (11) 
 Thus, for any voxel 𝐴 not lying at the boundary of the lattice, knowing the particle population 
of the voxel 𝑄𝑡(𝐴) and its neighbors 𝑄𝑡(𝐵𝑖),    𝑖 = 1, … ,26 at a time instant t, allows us 
calculate the population within A at the next time instant  t + Δτ by 
                             𝑄𝑡+𝛥𝜏(𝐴) = 𝑃𝑟(𝐴 → 𝐴)𝑄𝑡(𝐴) + ∑ 𝑃𝑟(𝐵𝑖 → 𝐴)𝑄𝑡(𝐵𝑖)
26
𝑖=1                       (12) 
For fixed Δτ, in the discrete time framework, equation (12) is equivalently written 
                           𝑄𝑡𝑝+1(𝐴) = 𝑃𝑟(𝐴 → 𝐴)𝑄𝑡𝑝(𝐴) + ∑ 𝑃𝑟(𝐵𝑖 → 𝐴)𝑄𝑡𝑝(𝐵𝑖)
26
𝑖=1                      (13) 
Under the assumption that particles are uniformly distributed within each voxel  and for 
properly chosen 𝛥𝑠 and 𝛥𝜏, equation (13) consists the discretization we propose and will be 
the basic tool we are going to use for modeling diffusion phenomena. The probabilities in this 
equation can be calculated numerically from the integral in (10). For remaining part of this 
section, we do not consider voxels lying at the boundary of the lattice nor voxels adjacent to 
it. We will deal with these voxels in detail in the next section, where we discuss boundary 
conditions. 
 Let the coordinates of each voxel in the lattice be given by a triad of integers, (𝑖, 𝑗, 𝑘) where 
𝑖, 𝑗, 𝑘 = 1, … , 𝑁. We define a mapping 𝐿: 𝑁3 → 𝑁 as follows: 𝐿(𝑖, 𝑗, 𝑘) =  𝑖 + (𝑗 − 1)𝑁 +
(𝑘 − 1)𝑁2. This mapping is a bijection from the space of triads (𝑖, 𝑗, 𝑘), 𝑖, 𝑗, 𝑘 = 1, … , 𝑁 to 
the integers from 1 to 𝑁3. Let 𝑄(𝑖, 𝑗, 𝑘) denote the number of particles in the respective voxel. 
We define a vector 𝑞 of 𝑁3 elements by 𝑞(𝐿(𝑖, 𝑗, 𝑘)) = 𝑄(𝑖, 𝑗, 𝑘), that is, we map the 
elements of the 3d matrix 𝑄 to the one dimensional vector 𝑞.  
Each voxel 𝐴 that is not lying at the boundary nor is adjacent to it, has 26 neighbors, which 
can be classified in 3 categories:  6 ones that share a common face with 𝐴, 12 that share a 
common edge with 𝐴 and 8 that share a common vertice with 𝐴. We denote these voxels by 
𝐹𝑙
𝐴, 𝑙 = 1, … ,6 , 𝐸𝑙
𝐴, 𝑙 = 1, … ,12, and 𝑉𝑙
𝐴, 𝑙 = 1, … ,8, respectively. Due to symmetry and 
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isotropy, (i.e. diffusion coefficient is a constant scalar) for any such voxel 𝐴 the following 
hold: 
-For any 𝑙1, 𝑙2 = 1, … ,6 ,   Pr(𝐹𝑙1
𝐴 → 𝐴) = Pr(𝐹𝑙2
𝐴 → 𝐴) 
-For any 𝑙1, 𝑙2 = 1, … ,12 , Pr(𝐸𝑙1
𝐴 → 𝐴) = Pr(𝐸𝑙2
𝐴 → 𝐴) 
-For any 𝑙1, 𝑙2 = 1, … ,8 ,   Pr(𝑉𝑙1
𝐴 → 𝐴) = Pr(𝑉𝑙2
𝐴 → 𝐴) 
We remind that each of these probabilities is defined and calculated by equations (8) and (10). 
Additionally, for any pair of voxels 𝐴 and 𝐵 not lying at the boundary nor adjacent to it, it 
holds  
-Pr(𝐴 → 𝐴) = Pr(𝐵 → 𝐵) 
-For any 𝑙1, 𝑙2 = 1, … ,6 ,   Pr(𝐹𝑙1
𝐴 → 𝐴) = Pr(𝐹𝑙2
𝐵 → 𝐵) 
-For any 𝑙1, 𝑙2 = 1, … ,12 , Pr(𝐸𝑙1
𝐴 → 𝐴) = Pr(𝐸𝑙2
𝐵 → 𝐵) 
-For any 𝑙1, 𝑙2 = 1, … ,8 ,   Pr(𝑉𝑙1
𝐴 → 𝐴) = Pr(𝑉𝑙2
𝐵 → 𝐵). 
The previous observations indicate that, given 𝑞𝑝, i.e. the vector of particle populations within 
each voxel at time instant 𝑝, by using equation (13) we can calculate each element of the 
vector  𝑞𝑝+1 that corresponds to a voxel not lying at the boundary, nor is adjacent to it, by 
using only four numbers: one for each neighbor category and one for the fraction of particles 
that were in 𝐴 and will remain in 𝐴. We denote these numbers by Pr(𝐹 → 𝐴), Pr(𝐸 → 𝐴), 
Pr(𝑉 → 𝐴) and Pr(𝐴 → 𝐴), respectively. These numbers can be precalculated by equations 
(8) and (10), where in each case, 𝐷 is taken to be the diffusion coefficient of the particles 
under consideration. 
However, to be able to calculate the remaining elements of the vector  𝑞𝑝+1, i.e. those that 
correspond to voxels at the boundary or adjacent to it, one must consider boundary conditions. 
This is the subject of the following section. 
 
IV. Dirichlet and Neumann boundary conditions. 
  Knowing the population of the particles within each voxel of the lattice at a time instant, 
equation (13) allows us to calculate the population within each voxel at the next time instant 
for all the voxels, except the ones at the boundary of the lattice and the ones that are adjacent 
to it. Each of the voxels lying at the boundary has less than 26 neighbors. In fact, each of 
these voxels would have 26 neighbors in an infinite lattice, but  not all of them are included in 
a bounded, 𝑁 × 𝑁 × 𝑁 lattice. Unless we specify boundary conditions, the calculation in (13) 
cannot be performed neither for those voxels and consequently, nor their neighbors. There are 
two types of boundary conditions that can be imposed in a classical diffusion problem, those 
of the Dirichlet type and those of the Neumann type. 
 Dirichlet boundary conditions express the requirement that at the boundary of the region 
under consideration, the quantity of interest does not change with time. In the framework 
presented here, this is expressed mathematically by the following:  If a voxel 𝐴 lies at the 
boundary of the lattice, to calculate its population at the next time instant, instead of equation 
(13) simply apply 𝑄𝐴(𝑡𝑝+1) = 𝑄𝐴(𝑡𝑝). Additionally, if a voxel is adjacent to the boundary, 
simply apply (13) by using the respective probabilities as they are calculated from (8) and 
(10). 
 Neumann boundary conditions express the requirement that at the boundary of the region 
under consideration, the flux of the quantity of interest is zero, i.e. the boundary is non-
permeable.  In terms of calculus this is expressed by the requirement, at any time instant and 
at any point of the boundary, the projection of the gradient of the quantity on the outward 
normal of the boundary at that point to be zero. In the stochastics literature, a non-permeable 
boundary within which a random motion takes place is often referred as a reflecting boundary 
[39]. In the framework presented here, this is expressed mathematically as follows. 
8 
 
 As previously mentioned, any voxel 𝐴 lying at the boundary has 17, 11 or 7 neighbor voxels 
which we denote by 𝐵𝑖, where 𝑖 is an integer from 1 to 17,11 or 7, depending on the position 
of the voxel.   For each such voxel  𝐴, we calculate the probabilities appearing in equation 
(13) only for the voxels that are contained in the lattice. Specifically, if 𝐴 lies at the boundary, 
we calculate the probabilities  Pr (𝐴 → 𝐴), Pr(𝐴 → 𝐵𝑖) where 𝑖 is an integer from 17, 11 or 7. 
We then normalize these probabilities to sum to one. By this calculation we acquire the 
probabilities we need, in order to apply equation (13) for any voxel in the lattice. Using these 
normalized  probabilities when applying  equation (13) for either boundary voxels , or their 
neighbors, ensures that every particle lying in a voxel at the boundary, will remain within the 
lattice, that is, within the region of interest, corresponding to the notion of reflecting 
boundary. 
  In our case, the region of interest is a cube; It is apparent, that these methods of imposing 
Dirichlet or Neumann boundary conditions apply to more complex shapes, as long as they are 
properly discretized. The case of glioblastoma, where the scull naturally imposes a reflecting 
boundary to the diffusion of glioma cells is an example where this approach may be useful. 
 
V. Diffusion of Glucose and Oxygen.    
  In this section we will use the previously developed ideas to model the diffusion of chemical 
molecules in the region of interest, that is, the cubic lattice of dimensions 𝑁 × 𝑁 × 𝑁. 
Assuming Dirichlet boundary conditions, equation (13) and the observations in section II 
imply that if we know 𝑞𝑝, i.e. the quantity of the molecules within each voxel at a time instant 
𝑡𝑝, we can calculate 𝑞𝑝+1 by performing a linear calculation. This means that there is a 
𝑁3 × 𝑁3  square matrix 𝑇 such that 𝑞𝑝+1 = 𝑇𝑞𝑝.  
  We remind that for each voxel 𝐴 not at the boundary, we can apply equation (13) by using 
only four numbers, which we respectively denote by Pr(𝐹 → 𝐴), Pr(𝐸 → 𝐴), Pr(𝑉 → 𝐴) and 
Pr(𝐴 → 𝐴). These numbers can be precalculated by equations (8) and (10), where in each 
case, 𝐷 is taken to be the diffusion coefficient of the respective molecule. We subsequently 
use these values to construct the matrix  𝑇 according to the following algorithm: 
Algorithm 1 
𝑇 =  𝑁3 × 𝑁3 zero matrix                                //initialization   
for each triad (𝑖, 𝑗, 𝑘)  𝑖, 𝑗, 𝑘 = 1, … , 𝑁 
     if the voxel with coordinates (𝑖, 𝑗, 𝑘) is at the boundary 
      𝑇(𝐿(𝑖, 𝑗, 𝑘), 𝐿(𝑖, 𝑗, 𝑘)) = 1                            // Dirichlet boundary condition    
     else 
        for 𝑑𝑖 = −1,0,1  𝑑𝑗 = −1,0, −1 𝑑𝑘 = −1,0,1   
             if       |𝑑𝑖| + |𝑑𝑗| + |𝑑𝑘| = 0 
                  𝑇(𝐿(𝑖, 𝑗, 𝑘), 𝐿(𝑖, 𝑗, 𝑘)) = Pr (𝐴 → 𝐴) 
             elseif |𝑑𝑖| + |𝑑𝑗| + |𝑑𝑘| = 1                     //common face neighbor 
                  𝑇(𝐿(𝑖, 𝑗, 𝑘), 𝐿(𝑖 + 𝑑𝑖, 𝑗 + 𝑑𝑗, 𝑘 + 𝑑𝑘)) = Pr (𝐹 → 𝐴)  
             elseif |𝑑𝑖| + |𝑑𝑗| + |𝑑𝑘| = 2                    //common edge neighbor                                                      
                  𝑇(𝐿(𝑖, 𝑗, 𝑘), 𝐿(𝑖 + 𝑑𝑖, 𝑗 + 𝑑𝑗, 𝑘 + 𝑑𝑘)) = Pr (𝐸 → 𝐴) 
             elseif |𝑑𝑖| + |𝑑𝑗| + |𝑑𝑘| = 3                    //common vertice neighbor 
                  𝑇(𝐿(𝑖, 𝑗, 𝑘), 𝐿(𝑖 + 𝑑𝑖, 𝑗 + 𝑑𝑗, 𝑘 + 𝑑𝑘)) = Pr (𝑉 → 𝐴) 
             end 
        end 
     end 
end 
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 To summarize, for each chemical species, we use (8) and (10) to calculate the four 
probabilities Pr(𝐹 → 𝐴), Pr(𝐸 → 𝐴), Pr(𝑉 → 𝐴) and Pr(𝐴 → 𝐴). We then apply the previous 
algorithm, to construct the respective matrix. In our model, we will use two such matrices, 
one for glucose and one for oxygen, denoted by 𝑇𝑔𝑙, 𝑇𝑜 respectively. We will use the 
notations  𝑔𝑙𝑝, 𝑜𝑝 to denote the each of 𝑁
3 vectors, whose elements are the molar quantities 
of glucose and oxygen within each voxel at time instant 𝑡𝑝.   
 For each case, the matrix constructed by the previous algorithm has some interesting 
properties. First, by equation (11) and the properties of the probabilities  Pr(𝐹 → 𝐴), Pr(𝐸 →
𝐴), Pr(𝑉 → 𝐴) and Pr(𝐴 → 𝐴) presented in the section I,  it is a stochastic matrix, i.e. the 
sum of each row is 1. Second, for sufficiently large 𝑁, and due to the assumption implied in 
equation (11), it is a sparse matrix: in each row, at most 26 elements are nonzero. This will 
provide a significant relief in the computational burden of the entire model.  
 
VI. The diffusion of living cells  
In the model we propose, there are two types of cell populations within each voxel, the living 
cells and the necrotic cells. In view of the mapping 𝐿 and the notation established in section 
III, let 𝑙𝑝, 𝑛𝑝 denote the 𝑁
3 × 1 vectors, whose entries are the populations of living and 
necrotic cells within each voxel at time instant 𝑡𝑝. Let 𝑢𝑝 denote the sum of  𝑙𝑝 and  𝑛𝑝, i.e. 
the total (live+necrotic) cell population within each voxel.  
 Starting from equation (13), we will construct an algorithm for simulating the diffusion of 
live cells. We do not directly apply the method developed in the previous section for two 
reasons.  The first reason is that we assume that only living cells are able to move. The second 
reason is that we assume that for any movement of cells between two neighboring voxels to 
happen, the total number of cancer cells (live +necrotic) should have reached a critical 
population in at least one of the two voxels. The implementation of a somewhat different 
hypothesis is presented in the appendix. In what follows, we denote that critical population by 
𝐶. Special care has been taken such that each term of the equations presented below, has a 
natural and intuitive meaning.  
 First we remind that, due to symmetry and the fact that we assume isotropic diffusion (i.e. 𝐷 
is a constant scalar) for any pair of neighboring voxels 𝐴, 𝐵 that do not lie at the boundary of 
the lattice nor adjacent to it, it holds    𝑃𝑟(𝐴 → 𝐵) = 𝑃𝑟 (𝐵 → 𝐴). For that particular case, we 
adopt the notation                                                  
                Pr(A → B) = Pr(B → A) = Pr(A ↔ B) = Pr(B ↔ A)                                    (14) 
 Taking into account equations (11), (14), for any voxel A not lying at the boundary of the 
lattice nor is adjacent to it, equation (13) takes the equivalent form 
               𝑄𝐴(𝑡𝑝+1) = 𝑄𝐴(𝑡𝑝) + ∑ Pr(𝐴 ↔ 𝐵𝑖)(𝑄𝐵𝑖(𝑡𝑝) − 𝑄𝐴(𝑡𝑝))
26
𝑖=1                                (15) 
 Verbally, equation (15) states that, the difference between cell populations  at two 
consecutive time instants within a voxel, is the algebraic sum of the net numbers of cells that 
moved between the voxel and each of its neighbors. If the voxel contains more cells than a 
particular neighbor, cells move from the voxel to the neighbor. Conversely, if the voxel 
contains fewer cells than a particular neighbor, cells move from the neighbor to the voxel. 
Note that based on the observations in section III, to apply equation (15) for voxels not lying 
in the boundary of the lattice nor are adjacent to it, we only need four numbers, which again, 
can be precalculated numerically from equations (8) and (10).    
  Let as now assume that we know  𝑙, 𝑛, 𝑢  at time instant 𝑡𝑝. Let 𝑛𝑒𝑥𝑡_𝑙 denote the vector of 
living cell populations due to diffusion at the next time instant. We use the notation  𝑙(𝐴) , 
𝑛(𝐴), 𝑢(𝐴)  to denote the living, dead and total cell population within a voxel 𝐴. The vector 
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of live cell populations due to diffusion of live cells at the next time instant is calculated by 
the following algorithm: 
Algorithm 2 
for each voxel 𝐴 in the lattice 
    if voxel 𝐴 and each of its neighbors have zero total population    
         𝑛𝑒𝑥𝑡_𝑙(𝐴) = 𝑙(𝐴)                                   // no diffusion                           
    else 
        𝑠 = 𝑙(𝐴) 
        for each of voxel’s 𝐴 neighbors 𝐵𝑖 
             if 𝑢(𝐴) ≥ 𝐶 or   𝑢(𝐵𝑖) ≥ 𝐶 
                  if 𝑢(𝐵𝑖) ≥ 𝑢(𝐴) 
𝑠 = 𝑠 +
𝑙(𝐵𝑖)
𝑢(𝐵𝑖)
Pr(𝐴 ↔ 𝐵𝑖)(𝑢(𝐵𝑖) − 𝑢(𝐴)) 
                  else 
𝑠 = 𝑠 +
𝑙(𝐴)
𝑢(𝐴)
Pr(𝐴 ↔ 𝐵𝑖)(𝑢(𝐵𝑖) − 𝑢(𝐴)) 
                  end 
             end 
        end 
        𝑛𝑒𝑥𝑡_𝑙(𝐴) = 𝑠 
    end 
end 
𝑙 = 𝑛𝑒𝑥𝑡_𝑙 
  
 The algorithm checks each voxel. If the voxel and its neighbors are all of zero total 
population, no movement of cells happens. If not, all pairs (𝐴, 𝐵𝑖)  of the voxel and its 
neighbors  are processed sequentially. For any movement of cells between the voxel and a 
particular neighbor to happen, at least one of them must have total cell population above the 
critical. If the voxel has lower total population than the particular neighbor, the quantity 
Pr(𝐴 ↔ 𝐵𝑖)(𝑢(𝐵𝑖) − 𝑢(𝐴)) provides the net number of cells that would have moved from 𝐵𝑖 
to 𝐴, if all cells within  𝐵𝑖 were alive: However, this is not always the case. Therefore we 
multiply this quantity by the ratio 𝑙(𝐵𝑖) 𝑢(𝐵𝑖)⁄ . If the voxel has higher total population than 
the particular neighbor, the quantity Pr(𝐴 ↔ 𝐵𝑖)(𝑢(𝐵𝑖) − 𝑢(𝐴)) provides the net number of 
cells that would have moved from 𝐴 to 𝐵𝑖, if all cells within 𝐴  were alive. Again, since this is 
not always the case, we multiply this quantity by 𝑙(𝐴) 𝑢(𝐴)⁄ . Note that the total population of 
living cells before and after the algorithm does not change: what is added to voxel 𝐴 from 𝐵𝑖, 
will be substracted from 𝐵𝑖 when the algorithm checks voxel 𝐵𝑖 and its neighbors. What is 
substracted from voxel 𝐴 to move to 𝐵𝑖 , will be added to 𝐵𝑖 when the algorithm checks voxel 
𝐵𝑖 and its neighbors.  
  Essentially, the algorithm is based on equation (15). However, for any particular voxel and 
any of its neighbors,  the algorithm checks additional conditions before adding  the respective 
term to the algebraic sum in (15).   
We note that by choosing a sufficiently large lattice and placing the initial tumor in the center 
of it, there is no need to impose Neumann conditions  in the  sense of section 2. In that case, 
cancer cells do not reach the boundary voxels nor their neighbors  and for all time steps these 
voxels are always processed  by the first if-statement of the algorithm. Thus, we can safely 
apply the previously described method. However, imposing Neumann boundary conditions in 
the sense of section 2 is totally feasible. The respective algorithmic implementation is more 
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involved. To avoid interrupting the flow and keep the presentation simple, we provide the 
details in the appendix.  
  Both algorithm 2 and algorithm 6 in the appendix are built on a spatially distributed 
dynamical systems perspective. Each element of the next state vector is calculated using only 
the elements of the previous state vector. Thus, each such calculation can be performed 
independently of the others rendering algorithms 2 and 6 suitable for exploiting multicore 
computation. 
 
V. Proliferation/necrosis of cancer cells and oxygen/glucose consumption 
In this section, we build the part of the model which at each time step, for each separate 
voxel, calculates the proliferation and necrosis of cancer cells, their consumption of glucose 
and oxygen, and their respective quantities within the voxel at the next time instant, 
neglecting for the moment diffusion-related phenomena. We will include diffusion-related 
calculations in the following section, where we present the complete structure the model. At 
each time step 𝑝, the input of this part consists of the four  𝑁3 × 1 vectors  𝑙𝑝, 𝑛𝑝, 𝑔𝑙𝑝, 𝑜𝑝 and 
the output of the respective vectors 𝑙𝑝+1, 𝑛𝑝+1, 𝑔𝑙𝑝+1, 𝑜𝑝+1. Based on the literature, we will 
make several assumptions and build an algorithm that distinguishes a variety of cases 
depending on cancer cell populations and oxygen/ glucose levels in the voxel under 
consideration.  
We introduce the following parameters: 
 𝑀, the average cell population capacity (cancerous +normal) per voxel.  
 𝐾𝑔𝑙, the average consumption of glucose for a normal cell of the host non-proliferating 
tissue. (units: pmol/sec) 
 𝐾𝑜, the average consumption of oxygen for a normal cell of the host non-proliferating 
tissue. (units: pmol/sec) 
 𝜆1, 𝜆2 ,  coefficients  assuming positive values, such that  𝜆1𝐾𝑔𝑙 , 𝜆2𝐾𝑜 are the average 
consumptions of glucose and oxygen for an actively proliferating cancer cell. Non-
proliferating cancer cells are assumed to consume the same amounts of glucose and 
oxygen as the host tissue cells. 
 𝑎𝑚𝑎𝑥 the generic, prefixed maximum mitosis rate of cancer cells per time step 𝛥𝜏. This 
parameter reflects the maximum mitosis rate of the cancer cells, when glucose and oxygen 
levels are ideal. 
 We will assume that initially, each voxel contains 𝑀 normal cells. As the tumor grows, these 
cells become either dislocated or apoptotic. Each normal cell consumes 𝐾𝑔𝑙 pmol glucose  and  
𝐾𝑜 pmol oxygen per second. This means that initially, in the absence of cancer cells, the blood 
supply network should provide in average 𝑀𝐾𝑔𝑙 and 𝑀𝐾𝑜 pmols of glucose and oxygen per 
second in each voxel, in order to keep oxygen and glucose levels at a constant level [40,41]. 
Let 𝐹𝑔𝑙, 𝐹𝑜 be the initial quantity of glucose and oxygen within each voxel. Mathematically, 
this means that at time  𝑝 = 0, for each voxel 𝐴 in the lattice, 𝑔𝑙0(𝐴) = 𝐹𝑔𝑙  and 𝑜0(𝐴)=𝐹𝑜.  
 The stoichiometry of the clean combustion of glucose requires that the glucose/oxygen 
uptake ratio is 1:6. It is well documented that for cancer cells, due to increased utilization of 
glycolysis, this is not the case [2]. Experimental measurements and estimations report that the 
ratio glucose /oxygen consumption in tumors can vary up to 1:1 or even more [18, 28, 29, 36, 
42, 44]. Compared to clean combustion, glycolysis is 18 times less efficient in ATP 
production  and cancer cells compensate this deficiency by upregulating glucose transporters, 
thereby increasing glucose import in the cytoplasm. Considerably increased glucose uptake 
and utilization has been reported in a variety of tumors by the use of positron emission 
tomography (PET) [2]. It is also reported that local levels of oxygen and glucose have an 
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effect on this ratio [18, 43]. Quantitative details of this effect are still unclear. The possibility 
that a single cell may employ both glycolysis and normal aerobic metabolism is not excluded.  
Qualitatively it seems evident, that when oxygen falls below a certain threshold, cells tend to 
switch to a glycolytic phenotype. However, this observation does not tell the whole story, 
since cancer cells switch to glycolysis even when oxygen levels are abundant [45,46].  In the 
cellular automaton model proposed in [27,28] the authors assumed that each cell can employ 
one of the two metabolic pathways, and when the local oxygen level is zero cells switch from 
aerobic metabolism to glycolysis. We opt for a different approach, more similar to [29]; as 
described in detail in what follows, for each simulation we fix the parameters 𝜆1 and  𝜆2 as 
average values and use them to calculate the proliferation of cells within each voxel as they 
are confined by the local levels of glucose and oxygen. It will become apparent that this may 
be easily readjusted; it is totally feasible to introduce an additional function determining the 
local 𝜆1 and  𝜆2 for the cells of a voxel by the voxel’s glucose and oxygen levels. We leave 
this for future work. Following several authors cited in the literature, we will assume that 
when oxygen or glucose levels within a voxel fall below certain respective thresholds, cells 
within that voxel start becoming necrotic. 
 As previously mentioned, tumor vasculature is highly irregular, and relative medical data are 
sparse. However, qualitative observations indicate that tumor growth affects preexisting 
vasculature even before the onset of angiogenesis. Vessels incorporated in the tumor mass 
may disintegrate or get obstructed [4]. The precise qualitative and quantitative details of this 
phenomenon remain largely unknown. However, since the focus in this work is on 
macroscopic quantities like local nutrient provision from the local blood supply network, a 
quantification of these effects on local host vasculature, and consequently on local nutrient 
provision, should be included. It is observed that for several tumors, the concentration of 
oxygen in the necrotic core of tumor  varies between 0.5% and 30% of the concentration in 
the surrounding tissue [5,27,28]. Thus, at a first approximation, we will make the assumption 
that if a voxel contains a percentage of necrotic tissue, i.e. a percentage of its 𝑀 cells is 
necrotic, the provision of glucose and oxygen through the blood supply network is reduced by 
the same percentage. We note that this assumption represents a correlational, rather than a 
causational relation between these quantities. Although this approach is somewhat 
oversimplifying, the entire structure of the algorithm enables readjustment so as to apply for 
more sophisticated scenarios, e.g. taking into account total cell density within a voxel or 
random fluctuations in the voxels’ local nutrient provision due to disorganized blood supply. 
Let us know suppose that at time instant 𝑝 we know  𝑙𝑝, 𝑛𝑝, 𝑔𝑙𝑝, 𝑜𝑝. Let 𝛥𝜏 be the time step 
of the simulation. For each voxel 𝐴 in the lattice, we distinguish the following cases.  
Case 1. 𝑙𝑝(𝐴) = 0, 𝑛𝑝(𝐴) = 0. In this case, the quantities of glucose and oxygen consumed 
by the normal cells within 𝐴 are provided by the blood supply network. Glucose and oxygen 
levels within 𝐴 do not change during 𝛥𝜏. Thus,    
𝑙𝑝+1(𝐴)= 𝑙𝑝(𝐴) 
𝑛𝑝+1(𝐴)= 𝑛𝑝(𝐴) 
𝑔𝑙𝑝+1(𝐴)=  𝑔𝑙𝑝(𝐴) 
𝑜𝑝+1(𝐴)= 𝑜𝑝(𝐴) 
Case 2. Glucose or oxygen levels are below certain respective thresholds. These states are 
known as hypoglycemia and hypoxia, respectively. It has been observed that in hypoxic areas 
within tumors the oxygen levels vary from 0.5% to 30% of the normal oxygen levels in non-
tumor areas. A typical respective threshold for hypoglycemia is 50% [47]. We will denote by 
ℎ𝑜,ℎ𝑔𝑙 these percentages. Thus, if  𝑔𝑙𝑝(𝐴) < ℎ𝑔𝑙𝐹𝑔𝑙  (𝐴 is hypoglycemic) or 𝑜𝑝(𝐴) < ℎ𝑜𝐹𝑜 (𝐴 
is hypoxic) living cancer cells should stop proliferating and start becoming necrotic. Cells that 
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stay alive consume glucose and oxygen provided by the blood supply and so, their respective 
levels remain constant.  Let 𝑟𝑛 be the necrosis rate. We have   
 
𝑙𝑝+1(𝐴)= 𝑙𝑝(𝐴) − 𝑟𝑛𝑙𝑝(𝐴) 
𝑛𝑝+1(𝐴)= 𝑛𝑝(𝐴) + 𝑟𝑛𝑙𝑝(𝐴) 
𝑔𝑙𝑝+1(𝐴)=  𝑔𝑙𝑝(𝐴) 
𝑜𝑝+1(𝐴)= 𝑜𝑝(𝐴) 
Case 3. 𝑙𝑝(𝐴) > 0, 𝑛𝑝(𝐴) = 0. 
 In this case we have several subcases: 
Case 3.1. 𝑙𝑝(𝐴) ≤ 𝑀, that is, living cancer cells within 𝐴 are below the average cell capacity 
of the voxel. Let 𝑎  be the mitosis rate of living cancer cells per time step 𝛥𝜏, i.e. the fraction 
of cells within 𝐴 that will divide during 𝛥𝜏 and 𝑐𝑐 the duration of their cell cycle. The 
duration of their cell cycle in time steps is 𝑐𝑐/𝛥𝜏. Assuming a uniform distribution of 
proliferating cells at all phases of the cell cycle, we estimate a total number 𝑎 ∙ 𝑙𝑝(𝐴) ∙
(𝑐𝑐/𝛥𝜏)  of actively proliferating cancer cells. Since 𝑀 is the average cell capacity of the 
voxels, apart from cancer cells, 𝐴 contains 𝑀 − 𝑙𝑝(𝐴) normal cells. We calculate the 
consumption rates of glucose and oxygen by all cells in 𝐴. 
 𝐺 = 𝑀𝐾𝑔𝑙 + 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆1 − 1)𝐾𝑔𝑙  pmol glucose/sec. The quantity 𝑀𝐾𝑔𝑙 is the 
amount of glucose consumed by cells in 𝐴 per second that is provided by the blood supply. 
Τhe quantity 
𝐺1 = 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆1 − 1)𝐾𝑔𝑙 
is the amount of glucose consumed by cells in 𝐴 per second that is not provided by the 
blood supply. The quantity 𝛥𝜏 ∙ 𝐺1 is the respective amount  of glucose consumed by cells 
in 𝐴 during the entire time step 𝛥𝜏. For any proliferation to happen, cancer cells should be 
able to acquire this amount from the quantity of glucose within 𝐴, i.e. 𝑔𝑙𝑝(𝐴) 
 𝑂 = 𝑀𝐾𝑜 + 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆2 − 1)𝐾𝑜  pmol oxygen/sec. The quantity 𝑀𝐾𝑜 is the 
amount of oxygen consumed by cells in 𝐴 per second that is provided by the blood 
supply.Τhe quantity 
𝑂1 = 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆2 − 1)𝐾𝑜 
is the amount of oxygen consumed by cells in 𝐴 per second that is not provided by the 
blood supply. The quantity 𝛥𝜏 ∙ 𝑂1 is the respective amount  of oxygen consumed by cells 
in 𝐴 during the entire time step 𝛥𝜏. For any proliferation to happen, cancer cells should be 
able to acquire this amount from the quantity of oxygen within 𝐴, i.e. 𝑜𝑝(𝐴). 
Subsequently, we solve the inequalities 
𝑔𝑙𝑝(𝐴) − 𝛥𝜏 ∙ 𝐺1 ≥ 0.05 ∙ 𝐹𝑔𝑙  and   𝑜𝑝(𝐴) − 𝛥𝜏 ∙ 𝑂1 ≥ 0.05 ∙ 𝐹𝑜 
with respect to 𝑎; Let 𝑎 ≤ 𝑎𝑔𝑙, 𝑎 ≤ 𝑎𝑜 be the solutions. The common solutions of these 
inequalities provide the maximum mitosis rate that 𝑎 that cancer cells can achieve at these 
levels 𝑔𝑙𝑝(𝐴), 𝑜𝑝(𝐴) of glucose and oxygen. We set 𝑎 = 𝑚𝑖𝑛(𝑎𝑔𝑙, 𝑎𝑜). We note that the 
right-hand sides of these inequalities could have been zero. To avoid  negative quantities that 
may appear from rounding during the simulation, we have chosen to insert these quantities as 
small (0.05, may be chosen to be even lower)  percentages of the concentrations of glucose 
and oxygen in normal tissue. If the maximum mitosis rate 𝑎 is larger than 𝑎𝑚𝑎𝑥, we set 
𝑎 = 𝑎𝑚𝑎𝑥, else 𝑎 remains as calculated from the above inequalities, i.e. 𝑎 =
𝑚𝑖𝑛(𝑎𝑔𝑙, 𝑎𝑜).Finally, for the next time instant 𝑝+1, we calculate 
𝑙𝑝+1(𝐴)= 𝑙𝑝(𝐴) + 𝑎𝑙𝑝(𝐴) 
𝑛𝑝+1(𝐴)= 𝑛𝑝(𝐴) 
𝑔𝑙𝑝+1(𝐴)=  𝑔𝑙𝑝(𝐴) − 𝛥𝜏 ∙ 𝐺1 
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𝑜𝑝+1(𝐴)= 𝑜𝑝(𝐴) − 𝛥𝜏 ∙ 𝑂1 
We note that Case 3 should be always checked after Case 2. This ensures that the maximum 
mitosis rates 𝑎𝑔𝑙, 𝑎𝑜 as calculated from the previous inequalities are nonnegative.  
Case 3.2 𝑙𝑝(𝐴) > 𝑀, i.e. living cancer cells within 𝐴 are above the average cell capacity of 
the voxel. Using the notation established in Case 3.1, we first calculate the consumption rates 
of glucose and oxygen by all cells in 𝐴. 
 
 𝐺 = 𝑀𝐾𝑔𝑙 + (𝑙𝑝(𝐴) − 𝑀)𝐾𝑔𝑙 + 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆1 − 1)𝐾𝑔𝑙 pmol glucose/sec. The 
quantity 𝑀𝐾𝑔𝑙 is the amount of glucose consumed by cells in 𝐴 per second that is provided 
by the blood supply. Τhe quantity 
𝐺1 = (𝑙𝑝(𝐴) − 𝑀)𝐾𝑔𝑙 + 𝑎𝑙𝑝(𝐴)(𝑐𝑐/𝛥𝜏)(𝜆1 − 1)𝐾𝑔𝑙 
 is the amount of glucose consumed by cells in 𝐴 per second that is not provided by the 
blood supply. The quantity 𝛥𝜏 ∙ 𝐺1 is the respective amount  of glucose consumed by cells 
in 𝐴 during the entire time step 𝛥𝜏. For any proliferation to happen, cancer cells should be 
able to acquire this amount from the quantity of glucose within 𝐴, i.e. 𝑔𝑙𝑝(𝐴) 
 𝑂 = 𝑀𝐾𝑜 + (𝑙𝑝(𝐴) − 𝑀)𝐾𝑜 + 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆2 − 1)𝐾𝑜  pmol oxygen/sec. The 
quantity 𝑀𝐾𝑜 is the amount of oxygen consumed by cells in 𝐴 per second that is provided 
by the blood supply. Τhe quantity 
𝑂1 = (𝑙𝑝(𝐴) − 𝑀)𝐾𝑜 + 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆2 − 1)𝐾𝑜 
 is the amount of oxygen consumed by cells in 𝐴 per second that is not provided by the 
blood supply. The quantity 𝛥𝜏 ∙ 𝑂1 is the respective amount  of oxygen consumed by cells 
in 𝐴 during the entire time step 𝛥𝜏. For any proliferation to happen, cancer cells should be 
able to acquire this amount from the quantity of oxygen within 𝐴, i.e. 𝑜𝑝(𝐴). 
Again, we solve the inequalities 
𝑔𝑙𝑝(𝐴) − 𝛥𝜏 ∙ 𝐺1 ≥ 0.05 ∙ 𝐹𝑔𝑙  and   𝑜𝑝(𝐴) − 𝛥𝜏 ∙ 𝑂1 ≥ 0.05 ∙ 𝐹𝑜 
with respect to 𝑎; Let 𝑎 ≤ 𝑎𝑔𝑙, 𝑎 ≤ 𝑎𝑜 be the solutions. There is no guarantee that 𝑎𝑔𝑙, 𝑎𝑜 are 
nonnegative; Therefore, we distinguish two further subcases. 
Case 3.2.1  Both 𝑎𝑔𝑙, 𝑎𝑜 are nonnegative. In this case, we set 𝑎 = 𝑚𝑖𝑛(𝑎𝑔𝑙, 𝑎𝑜). If the 
maximum mitosis rate 𝑎 is larger than 𝑎𝑚𝑎𝑥, we set 𝑎 = 𝑎𝑚𝑎𝑥, If not, it remains 𝑎 =
𝑚𝑖𝑛(𝑎𝑔𝑙, 𝑎𝑜). 
For the next time instant 𝑝+1, we calculate 
𝑙𝑝+1(𝐴)= 𝑙𝑝(𝐴) + 𝑎𝑙𝑝(𝐴) 
𝑛𝑝+1(𝐴)= 𝑛𝑝(𝐴) 
𝑔𝑙𝑝+1(𝐴)=  𝑔𝑙𝑝(𝐴) − 𝛥𝜏 ∙ 𝐺1 
𝑜𝑝+1(𝐴)= 𝑜𝑝(𝐴) − 𝛥𝜏 ∙ 𝑂1 
 
Case 3.2.2 At least one of 𝑎𝑔𝑙, 𝑎𝑜 is negative. In view of the previous inequalities resulting in 
𝑎𝑔𝑙, 𝑎𝑜, this implies that at least one of the quantities  
𝑔𝑙𝑝(𝐴) − 0.05 ∙ 𝐹𝑔𝑙 − 𝛥𝜏 ∙ (𝑙𝑝(𝐴) − 𝑀)𝐾𝑔𝑙 
𝑜𝑝(𝐴) − 0.05 ∙ 𝐹𝑜 − 𝛥𝜏 ∙ (𝑙𝑝(𝐴) − 𝑀)𝐾𝑜 
is negative. This means that cells within 𝐴 need more resources (oxygen, glucose or both) 
than those available (𝑔𝑙𝑝(𝐴), 𝑜𝑝(𝐴)) just for staying alive, without proliferation. We proceed 
as follows. First, we note that from the fact that we do not have necrotic tissue in the voxel 
under consideration i.e. 𝑛𝑝(𝐴) = 0, blood supply is adequate for all 𝑀 of 𝑙𝑝(𝐴) cells to 
survive (𝑙𝑝(𝐴) ≥ 𝑀). We divide 𝑔𝑙𝑝(𝐴)/(𝛥𝜏 ∙ 𝐾𝑔𝑙) and 𝑜𝑝(𝐴)/(𝛥𝜏 ∙ 𝐾𝜊) and set 𝑛𝑠 =
min (𝑔𝑙𝑝(𝐴)/(𝛥𝜏 ∙ 𝐾𝑔𝑙), 𝑜𝑝(𝐴)/(𝛥𝜏 ∙ 𝐾𝜊)). The number 𝑛𝑠 is the number of cells additional to 
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𝑀 that can survive during 𝛥𝜏 at these at these levels 𝑔𝑙𝑝(𝐴), 𝑜𝑝(𝐴) of glucose and oxygen. 
Again, to avoid negative quantities that may appear from rounding during the simulation, we 
set 𝑛𝑠 = 0.9 ∙ 𝑛𝑠. The coefficient 0.9 may be chosen to be larger, as long as it is smaller than 
1. Thus, apart from the 𝑀 living cells, an additional number of 𝑛𝑠 cells survives with no 
proliferation, consuming the necessary amounts of glucose and oxygen. Mathematically, for 
the next time instant 𝑝+1, this means. 
𝑙𝑝+1(𝐴)= 𝑀 + 𝑛𝑠 
𝑛𝑝+1(𝐴)= (𝑙𝑝(𝐴) − 𝑀) − 𝑛𝑠 
𝑔𝑙𝑝+1(𝐴)=  𝑔𝑙𝑝(𝐴) − 𝑛𝑠 ∙ 𝛥𝜏 ∙ 𝐾𝑔𝑙 
𝑜𝑝+1(𝐴)= 𝑜𝑝(𝐴) − 𝑛𝑠 ∙ 𝛥𝜏 ∙ 𝐾𝜊 
 
Case 4 𝑙𝑝(𝐴) ≥ 0, 𝑛𝑝(𝐴) > 0. 
We have several subcases. 
Case 4.1 𝑛𝑝(𝐴) ≥ 𝑀, i.e. the necrotic population within 𝐴 is larger than the average cell 
capacity of the voxel. 
Case 4.1.1 𝑛𝑝(𝐴) ≥ 𝑀 and 𝑙𝑝(𝐴) ≥ 0. In this case, 𝐴 contains more necrotic cells than its 
average cell capacity. We consider the voxel necrotic and that there is no blood reaching it. 
We calculate  the quantities 𝑔𝑙𝑝(𝐴)/(𝛥𝜏 ∙ 𝐾𝑔𝑙),  𝑜𝑝(𝐴)/(𝛥𝜏 ∙ 𝐾𝜊) and set 𝑛𝑠 = min ( 𝑔𝑙𝑝(𝐴)/
(𝛥𝜏 ∙ 𝐾𝑔𝑙), 𝑜𝑝(𝐴)/(𝛥𝜏 ∙ 𝐾𝜊) ). 𝑛𝑠 is the number of cells that can survive during 𝛥𝜏 at these at 
these levels 𝑔𝑙𝑝(𝐴), 𝑜𝑝(𝐴) of glucose and oxygen. Again, to avoid negative quantities that 
may appear from rounding during the simulation, we set 𝑛𝑠 = 0.9 ∙ 𝑛𝑠. There are two special 
subcases. 
Case 4.1.1.1 𝑙𝑝(𝐴) ≤ 𝑛𝑠. In this case, the number of cells that can survive during 𝛥𝜏 is larger 
than the living cell population within 𝐴. Thus, all living cells within 𝐴 survive with no 
proliferation, consuming the necessary amounts of glucose and oxygen.  Mathematically, this 
is expressed by the calculation 
𝑙𝑝+1(𝐴)= 𝑙𝑝(𝐴) 
𝑛𝑝+1(𝐴)= 𝑛𝑝(𝐴) 
𝑔𝑙𝑝+1(𝐴)=  𝑔𝑙𝑝(𝐴) − 𝑛𝑠 ∙ 𝛥𝜏 ∙ 𝐾𝑔𝑙 
𝑜𝑝+1(𝐴)= 𝑜𝑝(𝐴) − 𝑛𝑠 ∙ 𝛥𝜏 ∙ 𝐾𝜊 
Case 4.1.1.2 𝑙𝑝(𝐴) > 𝑛𝑠. In this case, glucose and oxygen levels do not suffice to keep all 
living  cells alive during 𝛥𝜏. Only 𝑛𝑠 of  𝑙𝑝(𝐴) cells will survive, consuming the necessary 
amounts of glucose and oxygen. For the next time instant 𝑝+1, we calculate 
𝑙𝑝+1(𝐴)= 𝑛𝑠 
𝑛𝑝+1(𝐴)= 𝑛𝑝(𝐴) + (𝑙𝑝(𝐴) − 𝑛𝑠) 
𝑔𝑙𝑝+1(𝐴)=  𝑔𝑙𝑝(𝐴) − 𝑛𝑠 ∙ 𝛥𝜏 ∙ 𝐾𝑔𝑙 
𝑜𝑝+1(𝐴)= 𝑜𝑝(𝐴) − 𝑛𝑠 ∙ 𝛥𝜏 ∙ 𝐾𝜊 
Case 4.1.2 𝑛𝑝(𝐴) ≥ 𝑀 and 𝑙𝑝(𝐴) = 0. In this case, voxel 𝐴 contains exclusively necrotic 
cells. Again, we consider the voxel necrotic and that there is no blood reaching it. For the next 
time instant 𝑝+1, everything remains as it is.  
𝑙𝑝+1(𝐴)= 𝑙𝑝(𝐴) 
𝑛𝑝+1(𝐴)= 𝑛𝑝(𝐴) 
𝑔𝑙𝑝+1(𝐴)=  𝑔𝑙𝑝(𝐴) 
𝑜𝑝+1(𝐴)= 𝑜𝑝(𝐴) 
Case 4.2 𝑛𝑝(𝐴) < 𝑀. There are the following special subcases. 
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Case 4.2.1  𝑛𝑝(𝐴) < 𝑀 and 𝑙𝑝(𝐴) ≤ 𝑀. In this case, 𝐴 contains a nonzero number of necrotic 
cells. We will assume that in this case, the amount of glucose and oxygen that reaches 𝐴 is 
(𝑀 − 𝑛𝑝(𝐴))/𝑀 times the amount in the case of zero necrosis within 𝐴. As in the cases 3.1 
and 3.2, we calculate the consumption rates of glucose and oxygen by all cells in 𝐴. 
 𝐺 = (𝑀 − 𝑛𝑝(𝐴))𝐾𝑔𝑙 + 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆1 − 1)𝐾𝑔𝑙  pmol glucose/sec. The quantity 
(𝑀 − 𝑛𝑝(𝐴))𝐾𝑔𝑙 is the amount of glucose consumed by cells in 𝐴 per second that is 
provided by the blood supply. 
Τhe quantity 
𝐺1 = 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆1 − 1)𝐾𝑔𝑙 
is the amount of glucose consumed by cells in 𝐴 per second that is not provided by the 
blood supply. The quantity 𝛥𝜏 ∙ 𝐺1 is the respective amount  of glucose consumed by cells 
in 𝐴 during the entire time step 𝛥𝜏. For any proliferation to happen, cancer cells should be 
able to acquire this amount from the quantity of glucose within 𝐴, i.e. 𝑔𝑙𝑝(𝐴) 
 𝑂 = (𝑀 − 𝑛𝑝(𝐴))𝐾𝑜 + 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆2 − 1)𝐾𝑜  pmol oxygen/sec. The quantity 
(𝑀 − 𝑛𝑝(𝐴))𝐾𝑜 is the amount of oxygen consumed by cells in 𝐴 per second that is 
provided by the blood supply. 
Τhe quantity 
𝑂1 = 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆2 − 1)𝐾𝑜 
is the amount of oxygen consumed by cells in 𝐴 per second that is not provided by the 
blood supply. The quantity 𝛥𝜏 ∙ 𝑂1 is the respective amount  of oxygen consumed by cells 
in 𝐴 during the entire time step 𝛥𝜏. For any proliferation to happen, cancer cells should be 
able to acquire this amount from the quantity of oxygen within 𝐴, i.e. 𝑜𝑝(𝐴). 
As in the cases 3.1 and 3.2, we subsequently solve the inequalities 
𝑔𝑙𝑝(𝐴) − 𝛥𝜏 ∙ 𝐺1 ≥ 0.05 ∙ 𝐹𝑔𝑙  and   𝑜𝑝(𝐴) − 𝛥𝜏 ∙ 𝑂1 ≥ 0.05 ∙ 𝐹𝑜 
with respect to 𝑎; Let 𝑎 ≤ 𝑎𝑔𝑙, 𝑎 ≤ 𝑎𝑜 be the solutions. We set 𝑎 = 𝑚𝑖𝑛(𝑎𝑔𝑙 , 𝑎𝑜). This is the 
maximum mitosis rate that cancer cells can achieve at these levels 𝑔𝑙𝑝(𝐴), 𝑜𝑝(𝐴) of glucose 
and oxygen. If the maximum mitosis rate 𝑎 is larger than 𝑎𝑚𝑎𝑥, we set 𝑎 = 𝑎𝑚𝑎𝑥, else 𝑎 
remains as calculated from the above inequalities, i.e. 𝑎 = 𝑚𝑖𝑛(𝑎𝑔𝑙, 𝑎𝑜). For the next time 
instant 𝑝+1, we calculate  
𝑙𝑝+1(𝐴)= 𝑙𝑝(𝐴) + 𝑎𝑙𝑝(𝐴) 
𝑛𝑝+1(𝐴)= 𝑛𝑝(𝐴) 
𝑔𝑙𝑝+1(𝐴)=  𝑔𝑙𝑝(𝐴) − 𝛥𝜏 ∙ 𝐺1 
𝑜𝑝+1(𝐴)= 𝑜𝑝(𝐴) − 𝛥𝜏 ∙ 𝑂1 
We note that Case 4.2.1 should be always checked after Case 2. This ensures that mitosis 
rates 𝑎𝑔𝑙, 𝑎𝑜 as calculated from the previous inequalities are nonnegative.  
 
 Case 4.2.2  𝑛𝑝(𝐴) < 𝑀 and 𝑙𝑝(𝐴) > 𝑀, i.e. the voxel contains a nonzero number of necrotic 
cells and a population of living cells larger than the average cell capacity of the voxel. We 
will again assume that the amount of glucose and oxygen that reaches 𝐴 is (𝑀 − 𝑛𝑝(𝐴))/𝑀 
times the amount in the case of zero necrosis within 𝐴. We calculate the consumption rates of 
glucose and oxygen by all cells in 𝐴. 
 𝐺 = 𝑀𝐾𝑔𝑙 + (𝑙𝑝(𝐴) − 𝑀)𝐾𝑔𝑙 + 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆1 − 1)𝐾𝑔𝑙 =  
    = (𝑀 − 𝑛𝑝(𝐴)) 𝐾𝑔𝑙 + 𝑛𝑝(𝐴)𝐾𝑔𝑙 + (𝑙𝑝(𝐴) − 𝑀)𝐾𝑔𝑙 + 
        + 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆1 − 1)𝐾𝑔𝑙 pmol glucose/sec. 
 The quantity (𝑀 − 𝑛𝑝(𝐴))𝐾𝑔𝑙 is the amount of glucose consumed by cells in 𝐴 per 
second that is provided by the blood supply. Τhe quantity 
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𝐺1 = 𝑛𝑝(𝐴)𝐾𝑔𝑙 + (𝑙𝑝(𝐴) − 𝑀)𝐾𝑔𝑙 + 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆1 − 1)𝐾𝑔𝑙 
is the amount of glucose consumed by cells in 𝐴 per second that is not provided by the 
blood supply. The quantity 𝛥𝜏 ∙ 𝐺1 is the respective amount  of glucose consumed by 
cells in 𝐴 during the entire time step 𝛥𝜏. For any proliferation to happen, cancer cells 
should be able to acquire this amount from the quantity of glucose within 𝐴, i.e. 
𝑔𝑙𝑝(𝐴) 
 𝑂 = 𝑀𝐾𝑜 + (𝑙𝑝(𝐴) − 𝑀)𝐾𝑜 + 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆2 − 1)𝐾𝑜 =  
    = (𝑀 − 𝑛𝑝(𝐴)) 𝐾𝑜 + 𝑛𝑝(𝐴)𝐾𝑜 + (𝑙𝑝(𝐴) − 𝑀)𝐾𝑜 + 
        + 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆1 − 1)𝐾𝑜  pmol oxygen/sec. 
 The quantity (𝑀 − 𝑛𝑝(𝐴))𝐾𝑜 is the amount of oxygen consumed by cells in 𝐴 per 
second that is provided by the blood supply. 
Τhe quantity 
𝑂1 = 𝑛𝑝(𝐴)𝐾𝑜 + (𝑙𝑝(𝐴) − 𝑀)𝐾𝑜 + 𝑎 ∙ 𝑙𝑝(𝐴) ∙ (𝑐𝑐/𝛥𝜏)(𝜆2 − 1)𝐾𝑜 
is the amount of oxygen consumed by cells in 𝐴 per second that is not provided by the 
blood supply. The quantity 𝛥𝜏 ∙ 𝑂1 is the respective amount  of oxygen consumed by 
cells in 𝐴 during the entire time step 𝛥𝜏. For any proliferation to happen, cancer cells 
should be able to acquire this amount from the quantity of oxygen within 𝐴, i.e. 
𝑜𝑝(𝐴). 
We subsequently solve the inequalities 
𝑔𝑙𝑝(𝐴) − 𝛥𝜏 ∙ 𝐺1 ≥ 0.05 ∙ 𝐹𝑔𝑙  and   𝑜𝑝(𝐴) − 𝛥𝜏 ∙ 𝑂1 ≥ 0.05 ∙ 𝐹𝑜 
with respect to 𝑎; Let 𝑎 ≤ 𝑎𝑔𝑙, 𝑎 ≤ 𝑎𝑜 be the solutions. There is no guarantee that 𝑎𝑔𝑙, 𝑎𝑜 are 
nonnegative; Therefore, we distinguish two further subcases. 
Case 4.2.2.1 Both 𝑎𝑔𝑙, 𝑎𝑜 are nonnegative. In this case, we set 𝑎 = 𝑚𝑖𝑛(𝑎𝑔𝑙, 𝑎𝑜). If the 
maximum mitosis rate 𝑎 is larger than 𝑎𝑚𝑎𝑥, we set 𝑎 = 𝑎𝑚𝑎𝑥, If not, it remains 𝑎 =
𝑚𝑖𝑛(𝑎𝑔𝑙, 𝑎𝑜). 
For the next time instant 𝑝+1, we calculate 
𝑙𝑝+1(𝐴)= 𝑙𝑝(𝐴) + 𝑎𝑙𝑝(𝐴) 
𝑛𝑝+1(𝐴)= 𝑛𝑝(𝐴) 
𝑔𝑙𝑝+1(𝐴)=  𝑔𝑙𝑝(𝐴) − 𝛥𝜏 ∙ 𝐺1 
𝑜𝑝+1(𝐴)= 𝑜𝑝(𝐴) − 𝛥𝜏 ∙ 𝑂1 
Case 4.2.2.2  At least one of 𝑎𝑔𝑙, 𝑎𝑜 is negative. In view of the previous inequalities resulting 
in 𝑎𝑔𝑙, 𝑎𝑜, this implies that at least one of the quantities 
𝑔𝑙𝑝(𝐴) − 0.05 ∙ 𝐹𝑔𝑙 − 𝛥𝜏 ∙ (𝑛𝑝(𝐴)𝐾𝑔𝑙 + (𝑙𝑝(𝐴) − 𝑀)𝐾𝑔𝑙) 
𝑜𝑝(𝐴) − 0.05 ∙ 𝐹𝑜 − 𝛥𝜏 ∙ (𝑛𝑝(𝐴)𝐾𝑜 + (𝑙𝑝(𝐴) − 𝑀)𝐾𝑜) 
is negative. As in case 3.2.2, this means that cells within 𝐴 need more resources (oxygen, 
glucose or both) than those available (𝑔𝑙𝑝(𝐴), 𝑜𝑝(𝐴)) just for staying alive, without 
proliferation. We note that blood supply is adequate for all 𝑀 − 𝑛𝑝(𝐴) of 𝑙𝑝(𝐴) cells to 
survive ( 𝑙𝑝(𝐴) ≥ 𝑀 ≥ 𝑀 − 𝑛𝑝(𝐴) ). We divide 𝑔𝑙𝑝(𝐴)/(𝛥𝜏 ∙ 𝐾𝑔𝑙) and 𝑜𝑝(𝐴)/(𝛥𝜏 ∙ 𝐾𝜊) and 
set 𝑛𝑠 = min (𝑔𝑙𝑝(𝐴)/(𝛥𝜏 ∙ 𝐾𝑔𝑙), 𝑜𝑝(𝐴)/(𝛥𝜏 ∙ 𝐾𝜊)). The number 𝑛𝑠 is the number of cells 
additional to 𝑀 − 𝑛𝑝(𝐴) that can survive during 𝛥𝜏 at these at these levels 𝑔𝑙𝑝(𝐴), 𝑜𝑝(𝐴) of 
glucose and oxygen. Again, to avoid negative quantities that may appear from rounding 
during the simulation, we set 𝑛𝑠 = 0.9 ∙ 𝑛𝑠. Thus, apart from the 𝑀 − 𝑛𝑝(𝐴) living cells, an 
additional number of 𝑛𝑠 cells survives with no proliferation, consuming the necessary 
amounts of glucose and oxygen. Mathematically, for the next time instant 𝑝+1, this means 
𝑙𝑝+1(𝐴)= (𝑀 − 𝑛𝑝(𝐴)) + 𝑛𝑠 
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𝑛𝑝+1(𝐴)= 𝑛𝑝(𝐴) + (𝑙𝑝(𝐴) − ((𝑀 − 𝑛𝑝(𝐴)) + 𝑛𝑠)) 
𝑔𝑙𝑝+1(𝐴)=  𝑔𝑙𝑝(𝐴) − 𝑛𝑠 ∙ 𝛥𝜏 ∙ 𝐾𝑔𝑙 
𝑜𝑝+1(𝐴)= 𝑜𝑝(𝐴) − 𝑛𝑠 ∙ 𝛥𝜏 ∙ 𝐾𝜊 
All the above cases are checked and the respective calculations are performed at each time 
instant, for each voxel in the lattice. We note that each separate case considered could be 
readjusted, in case different hypotheses need to be taken into account. This is made clear in 
the following section. 
VI. The complete model 
The model we propose can be seen as a discrete time dynamical system. The state of the 
system consists of the four 𝑁3 × 1 vectors  𝑙𝑝, 𝑛𝑝, 𝑔𝑙𝑝, 𝑜𝑝. In sections III, IV, V we have 
defined four operators.  
 The operator defined algorithmically in section V, which we denote by 𝑂1. Applying 
operator 𝑂1 to the state vector (𝑙𝑝, 𝑛𝑝, 𝑔𝑙𝑝, 𝑜𝑝) at each time instant, consists in 
checking all cases described in section V and performing the respective calculations 
for any voxel in the lattice. 
 The operators defined in section III, which we denote by 𝑂2, 𝑂3. These are actually the 
matrices 𝑇𝑔𝑙, 𝑇𝑜 defined in section III. Applying one of these operators to the state 
vector (𝑙𝑝, 𝑛𝑝, 𝑔𝑙𝑝, 𝑜𝑝) consists in multiplying the respective matrix (𝑇𝑔𝑙 or  𝑇𝑜) with 
the respective vector 𝑔𝑙𝑝 or 𝑜𝑝, thereby calculating how the respective molecule 
quantities within each voxel change due to diffusion. 
 The operator defined algorithmically in section IV, which we denote by 𝑂4. Applying 
operator 𝑂4 to the state vector (𝑙𝑝, 𝑛𝑝, 𝑔𝑙𝑝, 𝑜𝑝) consists in executing Algorithm 2 (or 
Algorithm 6 from the Appendix ) for the given vectors 𝑙𝑝, 𝑛𝑝, thereby calculating how 
living cell populations within each voxel change due to cell diffusion. 
Knowledge of these vectors allows us to calculate  𝑙𝑝+1, 𝑛𝑝+1, 𝑔𝑙𝑝+1, 𝑜𝑝+1 by the repeated 
application of the algorithm described in the following Diagram. 
 
 
 
 
 
 
  The entire architecture of the model is in compliance with approach presented in [48] and 
consists an extensible framework for modeling tumor growth.  Phenomena pertaining to 
diffusion of cells and molecules are modeled by separate operators (i.e. algorithmic modules) 
applied sequentially to the state vector. We note that, at least in principle, the application of 
these operators to the state vector is parallelizable. Within the proposed methodology, the 
algorithmic module corresponding to operator 𝑂1 is completely re-adjustable. This facilitates 
the simulation of scenarios based on different hypotheses concerning cell proliferation, 
necrosis and metabolism of chemical species. Introduction of additional diffusion operators 
like 𝑂2, 𝑂3 and extension of operator 𝑂1 according to different assumptions enables 
consideration of additional chemical species such as lactate and growth factors. Introduction 
𝑛𝑝 
𝑔𝑙𝑝 
𝑜𝑝 
 𝑙𝑝 
Application of 
operator 𝑂1 
𝑛𝑝̅̅ ̅ 
𝑔𝑙𝑝̅̅ ̅̅  
𝑜𝑝̅̅ ̅ 
 𝑙?̅? 
Application 
of operators 
𝑂2 and 𝑂3 
𝑛𝑝̅̅ ̅ 
𝑔𝑙𝑝̿̿ ̿̿  
𝑜𝑝̿̿ ̿ 
 𝑙?̅? 
Application of 
operator 𝑂4 
𝑙𝑝+1 
𝑛𝑝+1 
𝑔𝑙𝑝+1 
𝑜𝑝+1 
19 
 
of additional cellular species is also feasible, by appropriate readjustment of operators 𝑂4  and 
𝑂1. 
  As noted in [23], there is a large disparity between the time scales of cell proliferation and 
diffusion of chemical species. Instead of solving the reaction diffusion equations for each 
chemical species explicitly in time, the authors in [23] approached this problem by solving a 
sequence of equilibrium diffusion equations in a coarser time-scale. The method we present 
here, benefits from the sparse matrices constructed in section II and for small 𝛥𝜏 (in the order 
of 5-10 sec) affords a tractable computational implementation of both chemical fields 
evolution and cell proliferation. The problem is that for 𝛥𝜏 in the order of 5-10 sec, applying 
𝑂4 in each time step inflicts a significant computational burden in the entire simulation. 
However, diffusion coefficient of glucose and oxygen is in the order of 10−5 cm2/sec while 
the respective coefficient for cancer cells is in the order of 10−8 cm2/sec, reflecting a similar 
disparity in the time scales of chemical species and cell diffusion [21,27,28,36,37,49]. This 
allows applying operator 𝑂4  every several time steps, corresponding to a respective time scale 
of minutes, thereby substantially improving computational time. In the simulations described 
in the next section, we used a 10 sec time step, and applied 𝑂4 every 300 time-steps, i.e. 5 
mins.  
VI.Simulations  
In this section we will use the model developed previously to simulate various scenarios, 
primarily concerning the needs of proliferating cancer cells in glucose and oxygen relative to 
the normal quiescent cells and how they affect tumor growth. Quantitatively, it has been 
observed that proliferating cells consume 2-5 more resources than quiescent cells [30, 29, 43]. 
Therefore, we will vary the parameters 𝜆1 and 𝜆2 from in the interval from 1 to 6. Time step 
and voxel edge where chosen 𝛥𝜏 = 10 sec and 𝛥𝑠 = 2 mm. respectively. These values satisfy 
the assumptions in section I. The time step could be chosen to be even lower (down to 1-2 
secs), with some extra, although not severe impact on overall computational time. 
Furthermore, a voxel edge of  2 mm corresponds to the spatial resolution of contemporary 
MRI techniques [50]. The parameter values are presented in table 1. All simulations where 
initialized with a cancer cell population of 4∙106 cells.  
 
Table 1 
Parameter Symbol Value References and remarks 
Lattice size 𝑁 21  
Time step 𝛥𝜏 10 sec  
Voxel edge 𝛥𝑠 2 mm  
Average cell population capacity per 
voxel 
𝑀 8∙106cells/voxel Dionysiou et al 2004 
Oxygen Diffusion Coefficient 𝐷𝑜 1.8∙10
-5 
cm
2
/sec 
Gerlee&Anderson 2007,2008, 
Venkatasubramanian et al 2006, 
Schaller & Meyer-Hermann 2005, 2006 
Glucose Diffusion Coefficient 𝐷𝑔𝑙 1.05∙10
-5 
cm
2
/sec 
Gerlee&Anderson 2007,2008, 
Venkatasubramanian et al 2006, 
Schaller & Meyer-Hermann 2005, 2006 
Cell diffusion Coefficient 𝐷𝑐 
1.5∙10-8 to 1.5∙10-7  
cm
2
/sec 
Murray 2001 
Quiescent host cell Oxygen consumption 𝐾𝑜 50∙10
-6 
pmol/sec 
Kempf et al 2015, Freyer & Sutherland 
1985, Wherle et 2000 
Quiescent host cell Glucose consumption 𝐾𝑔𝑙 130∙10
-6 
pmol/sec 
Kempf et al 2015, Freyer & Sutherland 
1985, Wherle et 2000 
Critical Population  𝐶 8∙106 cells Dionysiou et al 2004 
Cell cycle duration 𝑐𝑐 24 hours Gerlee&Anderson 2007,2008 
Hypoxia threshold percentage ℎ𝑜 0.15 Gerlee&Anderson 2007,2008 
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Hypoglycemia threshold percentage ℎ𝑔𝑙 0.40 Gerlee&Anderson 2007,2008 
Maximum mitosis rate 𝑎𝑚𝑎𝑥 
8∙10-6 to 16∙10-6 
mitoses/10 sec 
Corresponds to a doubling time of 5 to 
10 days in ideal chemical conditions 
Necrosis rate 𝑟𝑛 
1.6∙10-5 cell 
deaths/ 10 sec 
Corresponds to a 5 day half-life of dying 
cells 
Oxygen per voxel in normal tissue 𝐹𝑜 1.2 ∙10
3 
pmol 
Kempf et al 2015, corresponding to 
concentration in capillary blood. 
Glucose per voxel in normal tissue 𝐹𝑔𝑙 40 ∙10
3 
pmol 
Kempf et al 2015, corresponding to 
concentration in capillary blood. 
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Figures 1-6 depict vertical sections of the graphical output of a simulation with parameter 
values as described in table 1, and 𝜆1=5, 𝜆2=1.7, 𝑎𝑚𝑎𝑥 = 16∙10
-6
 mitoses /10 sec. Total 
simulation time is 60 days, and the pictures are taken every 10 days. Figures 1a to 6a depict 
tumor expansion. Deep blue corresponds to voxels with total cell population above 𝐶/2 and 
more live than necrotic cells. Grey corresponds to voxels with total cell population above 𝐶/2 
and more necrotic than live cells. Black corresponds to voxels with total cell population above 
𝐶/2 and necrotic cell population above 1.5 times the living cell population within the voxel. 
Cyan corresponds to voxels containing total cell population less than 𝐶/2. Inspection of 
figures 1a to 6b show an agreement of the model with qualitative descriptions of tumor 
growth; Cells near the center of the tumor become necrotic, while an outer proliferating rim 
sustains tumor growth [29,51]. Figures 1b to 6b depict the spatiotemporal evolution of oxygen 
quantities in the lattice. Lightest color means that oxygen quantity within the voxel is intact. 
Black means that oxygen quantity within the voxel is below 15% of the respective oxygen 
quantity in intact tissue. The same holds for figures 1c to 6c, which depict the spatiotemporal 
evolution of glucose quantities. Lighter colors correspond to voxels with intact  glucose levels 
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and darker colors to lower glucose levels (black corresponds to 40% of intact tissue). 
Apparently, despite the fact that cancer cells consume more glucose than oxygen, the impact 
of tumor growth in the oxygen levels of neighboring tissue is much more severe than that in 
glucose levels. This is due to the fact that glucose levels are much higher than that of oxygen 
and therefore less sensitive to the respective increased consumption required by the cancer 
cells. Interestingly, inspection of figures 3b,4b and 5b show that a severely hypoxic 
environment has been formed in the center of the tumor in the 30
th
 day (fig. 3b), which is 
appears not so severe on the 40
th
 day ( fig. 4b); This is due to the fact that once oxygen levels 
fall below ℎ𝑜𝐹𝑜 , cells are assumed to start becoming necrotic and seize consuming more 
oxygen than provided (Section V case 2), thereby allowing diffusion of oxygen from 
neighboring voxels to restore oxygen levels. This necrosis is depicted in figure 3b by the 
black voxels. However, this restoration is only temporary (fig 5b.) As soon as oxygen levels 
allow some proliferation, cells start consuming more oxygen resources than supplied, and 
once again oxygen levels fall below ℎ𝑜𝐹𝑜.  
 All simulations showed that 𝜆2 i.e. the parameter determining the oxygen consumption of 
proliferating cancer cells has the most critical impact on tumor growth. Figures 7a to 7d 
depict tumor growth curves for 𝑎𝑚𝑎𝑥 = 16∙10
-6
 mitoses / 10 sec, 𝜆1=2, and  𝜆2=3,4,5,6 
respectively. 
 
Figure 7a. Proliferating cancer cells consume 3 times more oxygen than quiescent host cells. 
 
Figure 7b. Proliferating cancer cells consume 4 times more oxygen than quiescent host cells. 
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Figure 7c. Proliferating cancer cells consume 5 times more oxygen than quiescent host cells. 
 
Figure 7d. Proliferating cancer cells consume 6 times more oxygen than quiescent host cells. 
Figure 7. Blue line: living cells Black line: necrotic cells Green line: total (live+necrotic) 
cells. 
  In each case, the growth curve for living cells is initially exponentially increasing; All 
tumors reach a critical size, denoted by the red squares. Higher oxygen consumption implies 
lower (although not significantly) respective critical size and lower increase rate until this size 
is attended. Attending respective critical sizes is concurrent with the appearance of necrosis, 
and  all cases show a decrease in the living cell populations, whose severity increases with 
higher oxygen consumption; This is expected, since higher oxygen consumption causes more 
severely hypoxic regions, where, after a certain point oxygen restoration cannot be performed 
at an adequate rate by oxygen diffusion from the neighboring cells. In all cases, living cell 
populations continue to grow at a linear rate, which decreases with increasing oxygen 
consumption. 
 Subsequently, we simulated the following scenarios. For maximum mitosis rates of 8∙10-6, 
16∙10-6 mitoses/10 sec, corresponding respectively to doubling times of 10 and 5 days in ideal 
chemical conditions, we simulated growth curves for 𝜆2= 1.5 and 2, and  𝜆1 = 2 ,4 and 6.   
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Figure 8a. Proliferating cancer cells consume 1.5 times more oxygen and 2 times more 
glucose than host quiescent cells.     
 
Figure 8b. . Proliferating cancer cells consume 1.5 times more oxygen and 4 times more 
glucose than host quiescent cells.                  
 
Figure 8c. . Proliferating cancer cells consume 1.5 times more oxygen and 6 times more 
glucose than host quiescent cells.   
Figure 8. Blue line: living cells Black line: necrotic cells Green line: total (live+necrotic) 
cells. Doubling time in ideal conditions is 5 days. 
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In all figures 8a-8c, population of living cells shows an initial exponential increase, which 
later turns to linear. Glucose consumption appears to have an effect on tumor growth only in 
the third case (Figure 8c), where both necrosis and stopping of exponential growth appear 
earlier than in the other two cases, thereby affecting overall tumor growth. 
 
Figure 9a. Proliferating cancer cells consume 2 times more oxygen and 2 times more glucose 
than host quiescent cells.   
 
Figure 9b. Proliferating cancer cells consume 2 times more oxygen and 4 times more glucose 
than host quiescent cells.    
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Figure 9c. Proliferating cancer cells consume 2 times more oxygen and 6 times more glucose 
than host quiescent cells. 
Figure 9. Blue line: living cells Black line: necrotic cells Green line: total (live+necrotic) 
cells. Doubling time in ideal conditions is 5 days. 
 
In figures 9a-9c no impact of glucose consumption in overall tumor growth curves is 
observed. However, comparison of figures 9a-9a with figures 8a-8c reveals the impact of 
increased oxygen consumption. An increase in the order of 0.5 in 𝜆2 results in halving of the 
living cell population at day 60. 
 
Figure 10a. Proliferating cancer cells consume 1.5 times more oxygen and 2 times more 
glucose than host quiescent cells. 
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Figure 10b. Proliferating cancer cells consume 1.5 times more oxygen and 4 times more 
glucose than host quiescent cells. 
  
Figure 10c. Proliferating cancer cells consume 1.5 times more oxygen and 6 times more 
glucose than host quiescent cells. 
Figure 10. Blue line: living cells Black line: necrotic cells Green line: total (live+necrotic) 
cells. Doubling time in ideal conditions is 10 days. 
 
Comparison of figures 10a-10c with figures 8a-8c shows the effect of the maximum  doubling 
time of the cancer cells, which is attained in ideal conditions. Increasing that parameter leads 
to slower tumor growth. However, during the entire simulation time total cell population 
consists mainly of live cells; necrosis starts later, necrosis rates are slower than those in 
figures 8a-8c, and necrotic population never exceeds living cells. As in figures 8a-8c, the 
impact of increased glucose consumption is detectable only in figure 10c, but is much slighter 
that in the case of figure 8c. 
In figures 11a-11c necrosis starts later than in the respective cases depicted in figures 9a-9c 
and necrosis rates are much slower; The initial growth rate for living cells decreases slower 
than in the cases in figures 9a-9c, and necrotic population meets the living population  at the 
end of the simulation time. However, comparison of figures 11a-11c with figures 10a-10c 
reveals the impact of increasing oxygen consumption; In all cases at the end of the simulation 
time the tumor is smaller. As in figures 9a-9c, there is no detectable impact of increased         
glucose consumption. 
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Figure 11a. Proliferating cancer cells consume 2 times more oxygen and 2 times more glucose 
than host quiescent cells.  
 
Figure 11b. Proliferating cancer cells consume 2 times more oxygen and 4 times more 
glucose than host quiescent cells.  
 
Figure 11c. Proliferating cancer cells consume 2 times more oxygen and 6 times more glucose 
than host quiescent cells. 
Figure 11. Blue line: living cells Black line: necrotic cells Green line: total (live+necrotic) 
cells. Doubling time in ideal conditions is 10 days. 
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VI. Discussion and conclusions 
    We presented a modular framework for simulating tumor growth in a time varying 
chemical environment. Within this framework, we developed a model taking into account 
several phenomena observed during tumor progression, including diffusion of cells and 
molecules, consumption of chemical species by tumor cells, and cancer cell proliferation and 
necrosis. Simulations showed that for the scenarios tested, increased oxygen requirement by 
tumor cells can have a severe impact on tumor progression. In fact, the simulations depicted 
in figures 7a-7d show that when cells consume oxygen at higher rates than glucose (which 
phenomenologically corresponds to decreased utilization of glycolysis) the tumor practically 
cannot grow beyond a certain critical size; to grow any further, tumors must either decrease 
oxygen consumption and rely more on glucose (Figures 8,9,10,11) or establish their own 
blood supply network, thereby obtaining  more oxygen resources. Angiogenesis is often 
associated associated with early responses to hypoxia [52,53]. Simulations showed a 
nontrivial interplay between oxygen requirements and maximum mitosis rates. In the 
avascular phase, cells affording a higher mitosis rate in ideal conditions do not necessarily 
work in favor of tumor growth. Faster proliferation requires increased oxygen consumptions 
and more tumor areas become severely hypoxic more quickly and more permanently; oxygen 
diffusion from neighboring voxel does not suffice to restore oxygen levels and consequently, 
necrosis rates are higher. 
  Computationally, a one-month simulation of tumor growth required 2.5 mins. For two-
month simulations, this time rised to 5 or 6 mins. However, we note that many calculations 
performed by the model are parallelizable. For example, application of operators 𝑇2 and  𝑇3 to 
the state vector (𝑙𝑝, 𝑛𝑝, 𝑔𝑙𝑝, 𝑜𝑝) could be performed independently. Furthermore, as 
previously mentioned algorithm 2 (or algorithm 6 in the appendix) are built on a (spatially 
distributed) dynamical systems perspective; They are also, eligible for parallelization. 
 Future work should consider more details concerning cell metabolism, including 
production/consumption of lactate, hydrogen ion production and the effects of extracellular 
pH [19,21,23]. Currently, a further development of the model is elaborated, where effects of 
neovascularization on local concentrations of nutrients are considered by introducing random 
fluctuations on the supply of these quantities in neighboring voxels of the tumor. The 
parallelizability potential of certain parts of the model should also be explored. Introducing 
anisotropy to cancer cell movement seems to be an interesting endeavor; The methods 
described in [38] provide means for Monte Carlo approximations of the probabilities 
presented in section III.  
  From a clinical perspective, any adaptation/validation scenario dictates that the model should 
be able to “bridge” the gap between clinical data taken at two distinct time points, with no 
surgery in between. In this context, extending the model with additional modules facilitating 
utilization of actual, clinically obtained imaging data and taking account of the effects of 
various treatment strategies like chemo- and radiotherapy is of major importance.     
Appendix 
  Here we give implementation details on how to impose Neumann conditions on the 
boundary of the lattice. We will use the notation established in sections 1 and 3. Let 𝑙𝑝, 𝑛𝑝 
denote  the 𝑁3 × 1 vectors, whose entries are the populations of live and necrotic cells within 
each voxel at time instant 𝑡𝑝. Let 𝑢𝑝 denote the sum of  𝑙𝑝 and  𝑛𝑝, i.e. the total 
(live+necrotic) cell population within each voxel. For each voxel, let 𝐹 denote a common face 
neighbor, 𝐸 a common edge neighbor and 𝑉 a common face neighbor. Let  Pr (𝐴 →
𝐴), Pr (𝐴 → 𝐹), Pr (𝐴 → 𝐸), Pr (𝐴 → 𝑉) denote the probabilities calculated from equations  
(8) and (10) for voxels not lying at the boundary nor adjacent to it. 
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  First, we construct two 𝑁3 × 26 matrices, denoted by 𝑁𝑒𝑖𝑔ℎ𝑏𝑜𝑟𝑠 and 𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡𝑠 by the 
following algorithm 
Algorithm 3 
𝑁𝑒𝑖𝑔ℎ𝑏𝑜𝑟𝑠=𝑁3 × 26 zero matrix                             //initialization 
𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡𝑠 = 𝑁3 × 26 zero matrix 
for each triad (𝑖, 𝑗, 𝑘)  𝑖, 𝑗, 𝑘 = 1, … , 𝑁 
    𝑐𝑜𝑢𝑛𝑡𝑒𝑟 = 0 
    for 𝑑𝑖 = −1,0,1  𝑑𝑗 = −1,0, −1 𝑑𝑘 = −1,0,1   
       if the voxel with coordinates (𝑖 + 𝑑𝑖, 𝑗 + 𝑑𝑗, 𝑘 + 𝑑𝑘) is in the lattice 
             if  |𝑑𝑖| + |𝑑𝑗| + |𝑑𝑘| = 1                     //common face neighbor 
                 𝑐𝑜𝑢𝑛𝑡𝑒𝑟 = 𝑐𝑜𝑢𝑛𝑡𝑒𝑟 + 1 
                 𝑁𝑒𝑖𝑔ℎ𝑏𝑜𝑟𝑠(𝐿(𝑖, 𝑗, 𝑘), 𝑐𝑜𝑢𝑛𝑡𝑒𝑟) = 𝐿(𝑖 + 𝑑𝑖, 𝑗 + 𝑑𝑗, 𝑘 + 𝑑𝑘)    
                 𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡𝑠(𝐿(𝑖, 𝑗, 𝑘), 𝑐𝑜𝑢𝑛𝑡𝑒𝑟) = Pr (𝐴 → 𝐹) 
             elseif |𝑑𝑖| + |𝑑𝑗| + |𝑑𝑘| = 2                    //common edge neighbor                                                      
                𝑐𝑜𝑢𝑛𝑡𝑒𝑟 = 𝑐𝑜𝑢𝑛𝑡𝑒𝑟 + 1 
                𝑁𝑒𝑖𝑔ℎ𝑏𝑜𝑟𝑠(𝐿(𝑖, 𝑗, 𝑘), 𝑐𝑜𝑢𝑛𝑡𝑒𝑟) = 𝐿(𝑖 + 𝑑𝑖, 𝑗 + 𝑑𝑗, 𝑘 + 𝑑𝑘)    
                𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡𝑠(𝐿(𝑖, 𝑗, 𝑘), 𝑐𝑜𝑢𝑛𝑡𝑒𝑟) = Pr (𝐴 → 𝐸) 
             elseif |𝑑𝑖| + |𝑑𝑗| + |𝑑𝑘| = 3                    //common vertice neighbor     
               𝑐𝑜𝑢𝑛𝑡𝑒𝑟 = 𝑐𝑜𝑢𝑛𝑡𝑒𝑟 + 1 
               𝑁𝑒𝑖𝑔ℎ𝑏𝑜𝑟𝑠(𝐿(𝑖, 𝑗, 𝑘), 𝑐𝑜𝑢𝑛𝑡𝑒𝑟) = 𝐿(𝑖 + 𝑑𝑖, 𝑗 + 𝑑𝑗, 𝑘 + 𝑑𝑘)    
              𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡𝑠(𝐿(𝑖, 𝑗, 𝑘), 𝑐𝑜𝑢𝑛𝑡𝑒𝑟) = Pr (𝐴 → 𝑉) 
             end    
       end 
    end  
end 
 
  In view on the numbering of the voxels defined by the mapping 𝐿, we denote the 𝑖th voxel of 
the lattice by 𝐴. The 𝑖th row of the matrix 𝑁𝑒𝑖𝑔ℎ𝑏𝑜𝑟𝑠 contains the neighbors of 𝐴, as they are 
enumerated by 𝐿. Note that if  𝐴  lies at the boundary, the respective row has less than 26 
nonzero entries. The nonzero entries of such a row can be 17,11 or 7, depending on the 
position of the 𝐴. The entry at the 𝑖th row, 𝑗th column of the matrix 𝑁𝑒𝑖𝑔ℎ𝑏𝑜𝑟𝑠 is a neighbor 
𝐵 of  𝐴, provided it is nonzero. The respective (𝑖, 𝑗) entry of the matrix 𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡𝑠  is the 
number Pr (𝐴 → 𝐵). 
Apparently, the probabilities contained in rows with less than 26 nonzero entries are 
unnormalized. The following algorithm normalizes them. Initially, let 𝑆𝑡 denote a 𝑁3 × 1 
vector, initially containing the number Pr (𝐴 → 𝐴) in all of its entries. 
Algorithm 4 
for 𝑖=1 to 𝑁3 
    if nonzero elements in 𝑖th row of the matrix 𝑁𝑒𝑖𝑔ℎ𝑏𝑜𝑟𝑠 are less than 26 
      Calculate 𝑠𝑢𝑚 = ∑ 𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑒𝑛𝑡𝑠(𝑖, 𝑗)26𝑗=1 + 𝑆𝑡(𝑖) 
      𝑆𝑡(𝑖) = 𝑆𝑡(𝑖)/𝑠𝑢𝑚 
         for each 𝑗 such that  𝑁𝑒𝑖𝑔ℎ𝑏𝑜𝑟𝑠(𝑖, 𝑗) is nonzero 
           𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑒𝑛𝑡𝑠(𝑖, 𝑗) = 𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑒𝑛𝑡𝑠(𝑖, 𝑗)/𝑠𝑢𝑚 
         end 
    end 
end 
 The previous algorithm normalizes the probabilities contained in each row of the matrix 
𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑒𝑛𝑡𝑠 and the vector 𝑆𝑡, and at the same time. The final step is to construct a  𝑁3 × 26 
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matrix denoted 𝑃𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑖𝑒𝑠  with the following property: Using the notation of the 
previous paragraph, the 𝑖th row- 𝑗th column entry of that matrix should be the probability  
Pr (𝐵 → 𝐴). This matrix, along with the vector 𝑆𝑡 will subsequently be used to algorithmically 
implement the modeling of living cell diffusion. The matrix 𝑃𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑖𝑒𝑠 is constructed as 
follows: 
Algorithm 5 
𝑃𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑖𝑒𝑠=𝑁3 × 26 zero matrix                             //initialization 
for 𝑖=1 to 𝑁3 
     for each 𝑗 = 1 to 26 such that  𝑁𝑒𝑖𝑔ℎ𝑏𝑜𝑟𝑠(𝑖, 𝑗) is nonzero 
        Set 𝑘 = 𝑁𝑒𝑖𝑔ℎ𝑏𝑜𝑟𝑠(𝑖, 𝑗)   
        Find the 𝑚th column of 𝑁𝑒𝑖𝑔ℎ𝑏𝑜𝑟𝑠 such that 𝑁𝑒𝑖𝑔ℎ𝑏𝑜𝑟𝑠(𝑘, 𝑚) = 𝑖 
        Set 𝑃𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑖𝑒𝑠(𝑖, 𝑗) = 𝐶𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡𝑠(𝑘, 𝑚)      
     end 
end 
Finally, the algorithmic implementation of living cell diffusion model with Neumann 
boundary conditions is as follows. 
Algorithm 6 
for each voxel 𝐴 in the lattice with resp. coordinates (𝑖, 𝑗, 𝑘) 
    if voxel 𝐴 and each of its neighbors have zero total population    
         𝑛𝑒𝑥𝑡_𝑙(𝐴) = 𝑙(𝐴)                                   // no diffusion                           
    else 
        if 𝑢(𝐴) ≥ 𝐶 
            𝑠 = 𝑆𝑡(𝐿(𝑖, 𝑗, 𝑘))𝑙(𝐴) 
        else 
            𝑠 = 𝑙(𝐴) 
        end  
        for each 𝑚 = 1 to 26 such that  𝑁𝑒𝑖𝑔ℎ𝑏𝑜𝑟𝑠(𝐿(𝑖, 𝑗, 𝑘), 𝑚) is nonzero 
                if 𝑢(𝐵𝑖) ≥ 𝐶 
                  𝑠 = 𝑠 + 𝑃𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑖𝑒𝑠(𝐿(𝑖, 𝑗, 𝑘), 𝑚)𝑙(𝐵𝑖) 
                end 
        end 
        𝑛𝑒𝑥𝑡_𝑙(𝐴) = 𝑠 
    end 
end 
𝑙 = 𝑛𝑒𝑥𝑡_𝑙 
Again, this algorithm leaves the total population of living cells unchanged. We note that the 
biological meaning reflected on algorithm 6 is slightly different from that on algorithm 2 in 
the main text. In algorithm 6, for the living cells within any voxel to start invading 
neighboring voxels, cancer cells within it should have first reached a critical total 
(live+necrotic) population. In algorithm 2, for any movement of cells between two 
neighboring voxels to happen, the total number of cancer cells (live +necrotic) should have 
reached a critical population in at least one of the two voxels. However, both algorithms are 
based on the same core ideas. From the performed simulations, it seems that there are no 
major differences in the results. To keep the presentation of the core ideas as simple as 
possible, we opted to put the first version in the main text. 
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